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Abstract 
 
The development of regulatory T (Treg) cells is essential for the maintenance of 
immune tolerance and homeostasis. In the thymus, TCR-specificity to self-antigen 
appears to be a primary determinant for Treg cell lineage commitment, imprinting both 
self and foreign antigens in the peripheral Treg cell population to provide dominant 
tolerance. The degree of T cell self-reactivity considered dangerous by the immune 
system, thereby requiring thymic education to prevent autoimmunity, is unknown. Here, I 
analyzed a panel of TCRs with a broad range of reactivity to ovalbumin (OVA323-339) in 
the RIP-mOVA self-antigen model for their ability to induce mechanisms of thymic 
tolerance.  Thymic Treg cell generation in vivo was directly correlated with reactivity to 
OVA-peptide in a broad ~1,000-fold range, and its developmental “niche size” was 
unexpectedly dependent on TCR affinity.  The threshold for Treg cell differentiation was 
almost 100-fold lower than that required for eliciting thymic negative selection and 
peripheral T cell responses. Thus, these data suggest that Treg cell differentiation is a 
default outcome of self-antigen encounter for CD4
+
 thymocytes, and that thymic 
tolerance mechanisms are tuned to limit the escape of self-reactive effectors without Treg 
cell chaperones into the periphery. In addition, in the study of developmental stage of 
Treg cells, I demonstrated that differentiation of most Treg cells occurs at immature 
CD4SP subset, suggesting that medullary APCs may facilitate maturation of thymocyte 
after positive selection for efficient induction of Foxp3. In summary, this study suggest 
that Treg cell development is driven by self-antigen encounter of CD4SP cells, and TCR 
reactivity for self-antigen plays an instructive role in Treg cell differentiation, thereby 
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thymic tolerance mechanisms prevent autoimmunity by restraining the escape of self-
reactive effector T cells into the periphery.   
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Chapter 1 
Background and Significance 
 
It has become well established that the naturally occurring regulatory subset (Treg) 
of CD4
+
 T cells plays an important role in maintaining immune tolerance [1-3].  This is 
clearly illustrated by the observation that mutations in the forkhead transcription factor 
Foxp3, important for Treg cell function and development, results in lethal multi-organ 
autoimmunity.  In humans, children are afflicted by the IPEX syndrome 
(immunodysregulation polyendocrinopathy and enteropathy) [4], whereas the murine 
equivalent is termed scurfy [5, 6].  Moreover, the acute depletion of Foxp3
+
 Treg cell 
from normal mice unleashes a rapid diffuse lymphoproliferative syndrome leading to 
death within 2 weeks [7, 8]. Treg cells have also been shown to prevent excessive 
responses to pathogens, participate in immune surveillance on tumor cells, and control a 
balance between host and microbial flora [9-11]. In order to understand how Treg cells 
impact on these multiple facets of immunity, it is important to determine how Treg cells 
are generated.   
 
Brief history of thymic Treg cell development  
In order to recognize a wide variety of pathogens, the adaptive immune system 
generates an enormously diverse repertoire of antigen receptors by somatic gene 
rearrangement. One consequence of this diversity, however, is that the repertoire includes 
receptors that recognize self-antigen with the potential to cause autoimmunity. For T cells, 
the immune system utilizes an intricate system of development in a specialized organ, the 
thymus, to educate the immature T cell population to self prior to their release into the 
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periphery. One mechanism of education is the elimination of immature self-reactive cells, 
a process also known as negative selection [12-14] . However, it has become clear that 
this culling is not sufficient to achieve tolerance, and some potentially pathogenic cells 
escape into the periphery [15, 16].  
The notion that a specialized regulatory T cell population is required to inhibit the 
cells that escape negative selection was suggested by the classic thymectomy experiment, 
in which T cell dependent autoimmunity occurred if thymectomy occurred at day 3, but 
not day 7 [17], resulting from what is now thought to be a delay in thymic Treg cell 
export [18, 19]. Follow up studies showed that depletion of the CD25 subset revealed the 
autoimmune propensity in CD4 single-positive (SP) thymocytes [20]. Thus, it was 
suggested that another important educational function of the thymus is to select 
regulatory T (Treg) cells to prevent spontaneous autoimmunity [21]. 
 
TCR specificity: Self-reactivity of thymic Treg cells 
Since Foxp3
+
 Treg cells comprise only a small fraction of CD4
+
 T cells, an 
important question is whether there are defining features that determine selection into the 
Treg cell subset. Early studies inferred that Treg cells may be reactive to self antigens, as 
the presence of an organ was required for the maintenance or generation of peripheral T 
cells with the ability to suppress autoimmunity to that tissue [22-24]. Subsequent studies 
were more direct. For example, it was observed that superantigen increased the frequency 
of Treg cells with the appropriate TCRβ chain, suggesting that TCR stimulation was 
involved in thymic Treg cell development [25].  Moreover, TCR transgenic mice on a 
Rag-deficient background were not found to contain thymic Treg cells, whereas Rag-
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sufficient mice, able to rearrange endogenous TCRα chains, could generate thymic Treg 
cells [20, 26]. These data therefore suggested that only certain TCR specificities could 
facilitate thymic Treg cell development.   
 Studies of TCR and cognate antigen transgenic mice provided direct support for 
the hypothesis that self-antigen recognition in the thymus was important for directing 
thymic Treg cell selection.  For example, hemagglutinin (HA) specific TCR transgenic 
cells were selected to become Treg cells only when HA was transgenically expressed in 
the thymus [27].  Other TCR transgenic models including ovalbumin (OVA) -specific 
DO11.10 yielded similar results [28, 29]. From these data, the notion arose that Treg cell 
development occurred in the avidity window for self-antigen between positive and 
negative selection [30]. 
 However, subsequent data were conflicted regarding whether intrinsic properties 
of TCR, such as self-reactivity, specify Treg lineage commitment. In hen egg lysozyme 
(HEL)-specific 3A9 TCR transgenic mice, analyses of the absolute number of Treg cells 
revealed no significant increase in Treg cell generation when transgenic TCR was 
coexpressed with HEL [31]. Similarly, it was found that the proportion of Treg cells 
increased without an increase of the absolute numbers when pigeon cytochrome c (PCC) 
- reactive AND TCR encountered varying amount of antigen expressed under the control 
of tetracycline-dependent transgene system [32] . This observation suggested that agonist 
TCR interaction resulted in deletion, rather than Treg cell selection. However, TCR 
specificities induced by alternative TCRα chain usage could induce Treg cells and protect 
them from agonist mediated deletion, resulting in an overall increase in the frequency of 
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Treg cells with increasing agonist ligands. Thus, not all TCR transgenic studies supported 
an agonist model of Treg cell selection.    
 Analyses of polyclonal TCR repertoire also reached conflicting conclusions.  It 
was reported that Treg cells utilize a distinct, but overlapping, TCR repertoire from that 
of non-Treg cells, in favor of a model in which Treg lineage commitment is instructed by 
TCR specificity [33-35]. Moreover, T cells transduced with Treg TCRs often rapidly 
expanded after adoptive transfer into either normal or lymphopenic hosts, suggesting that 
Treg-derived TCRs confer reactivity to self-antigens in vivo [33, 36]. In contrast, another 
study argued that self-reactivity is dispensable for Treg cell selection, based on the 
observations that TCR repertoire of Treg  and non-Treg cell subset were significantly 
overlapped, and hybridoma cells expressing Treg TCRs failed to respond to self-antigens 
presented by splenocytes or dendritic cells in vitro [37].  
 Finally, it was suggested that early thymic developmental events condition 
thymocytes for differentiation into Treg cell lineage before TCR rearrangement, implying 
that TCR specificity is not a specifying factor for thymic Treg cell induction, although 
post-differentiation selection based on antigen-specificity is possible [38]. Thus, there 
was considerable controversy regarding the role of TCR specificity in thymic Treg cell 
selection. 
Data from the past several years, however, have been in favor of TCR-mediated 
Treg cell selection. First, TCRs from natural Treg, but not naive, cells, are able to 
facilitate thymic Treg cell development in TCR transgenic models [39, 40]. Second, 
experimental attenuation of MHC II expression on mTECs resulted in preferential Treg 
development, rather than negative selection, in a TCR transgenic model involving an 
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Aire-promoter driven antigen [41]. Third, intravenous peptide could stimulate Treg cell 
development if given within certain dose ranges [42]. Finally, direct assessment of TCR 
activation using a new Nur77-GFP reporter revealed that thymic Treg cells were recently 
exposed to enhanced levels of TCR stimulation [43]. Thus, the preponderance of current 
evidence, discussed in greater detail below, supports an important role for TCR 
specificity in thymic Treg cell differentiation.  
 
TCR transgenic mice with natural Treg TCRs 
The aforementioned TCR transgenic studies utilized TCRs that were not known to 
be normally found in the natural Treg cell population. It was therefore possible that the 
experimental manipulation of expressing the cognate antigen using various promoters 
may not mimic natural Treg cell development. Recently, several groups independently 
reported their experiences with TCR transgenic mice expressing natural Treg TCRs. One 
group isolated the natural Treg TCR from OTII -TCR transgenic cells, and only 
observed negative selection after generating the Treg TCR transgenic line [44]. It is 
possible that this particular TCR was expressed as a secondary TCR chain at low levels 
in OTII cells, and therefore had higher affinity than usual for self antigens leading to 
negative selection when expressed in a normal context. Two other groups used TCRs 
isolated from polyclonal fixed TCRrepertoires in which the skewing of the TCR to the 
Treg cell subset was known [39, 40]. Intriguingly, the frequency of Foxp3
+
 thymocytes 
was surprisingly low in the TCR transgenic mice on a Rag-deficient background, which 
would not have been predicted based on previous studies of TCR by cognate antigen 
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transgenic mice [27-29]. In fact, the initial interpretation by both groups was that this 
observation resulted from an experimental artifact of TCR transgenesis.  
Substantial thymic Treg cell development was eventually observed only when the 
clonal frequency of the TCR transgenic cells was diminished using either mixed bone 
marrow chimeras or intrathymic injection.  In other words, the clonal frequency of TCR 
transgenic cells was inversely correlated with the frequency of Foxp3
+
 cells. Moreover, 
the number of Treg cells generated reached plateau at high clonal frequency, and was 
much smaller than the total number of CD4
+
CD8
–
 (CD4SP) cells that could be generated 
by positive selection. These observations led to the notion that thymocytes with a given 
TCR specificity undergo intraclonal competition for a small niche with limited 
microenvironmental factor(s) important for thymic Treg cell development. Although the 
factors defining the Treg cell selection niche are unclear, the most compelling hypothesis 
is that the niche represents a limited amount of antigen for which developing thymocytes 
must compete in order to undergo Treg cell differentiation. 
It is important to note, however, that the limitations imposed by niche size 
resulting in intra-(or inter) clonal competition may be more applicable to experimental 
immunology rather than normal T cell development in a fully polyclonal population, 
where the clonal frequency is likely to be extremely low–on the order of a few to tens of 
cells per antigen specificity [45]. In addition to TCR transgenic mice, restricted TCR 
repertoires may be susceptible to niche size issues depending on the extent of the 
limitation [35], and may provide an explanation regarding the increased overlap between 
Treg and non-Treg cell subsets in some studies [37] compared with others [33] .   
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The more physiologic implication from the observation of a small Treg cell 
developmental niche, at least based on the natural Treg TCRs reported to date, is that the 
antigens that drive thymic Treg cell development are likely to be uncommon and likely 
tissue-specific antigens, rather than ubiquitous antigens. Moreover, the size of the niche 
varies per TCR, suggesting that some Treg TCR ligands are more abundant than others. 
The notion of rare Treg cell-inducing ligands would be consistent with the notion that 
Aire-dependent tissue specific antigens presented by medullary thymic epithelial cells 
(mTECs) can facilitate thymic Treg cell development [46]. This is also supported by an 
observation of preferred Treg cell development compared to deletion in low amount of 
antigen expression [47]. Finally, uncommon self-ligands would explain why self-
reactivity could not be easily detected by direct hybridoma assays [37], but required 
assessment of in vivo proliferation in lymphopenic hosts [33, 36].  Direct proof of this 
hypothesis will require isolation of natural Treg TCR ligands, which has not yet been 
reported to our knowledge. Thus, the preponderance of current data suggests that thymic 
Treg cell selection is driven by TCR encounter with rare self-antigens. 
 
Affinity and avidity 
As TCR specificity is a primary determinant for thymic Treg cell selection, an 
important question is to understand the parameters of TCR:ligand engagement required 
for this process. Initial experiments with TCR transgenic models suggested that a high 
affinity TCR interaction is required for thymic Treg cell selection. Comparison of two 
HA-specific TCR transgenic lines with 1000 fold differences in sensitivity to HA 
revealed that Treg cell development only occurred with the high affinity TCR [27]. 
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Increasing the amount of antigen, i.e. avidity, could not compensate for the difference in 
affinity, as levels of antigen sufficient to induce negative selection were still unable to 
generate Foxp3
+
 cells. A different study of Treg cell differentiation in thymic organ 
cultures used altered peptide ligands (APL) with varying affinities to the hemoglobin-
specific N3.L2 TCR [48]. They observed that strong and weak agonist, but not antagonist, 
peptides could induce Treg cell differentiation.  Thus, these data suggest that there may 
be an affinity threshold, akin to negative selection [13], for which TCR recognition of 
agonist ligands is required for thymic Treg cell differentiation.  
The role of the avidity in Treg cell differentiation has been also addressed using 
transgenic mice and in vitro thymic organ cultures. Using a panel of transgenic lines with 
different expression levels of HA in the thymus, it was observed that Treg cell number 
was enhanced at low expression levels, whereas high levels resulting predominantly in 
negative selection [47]. A similar monophasic response was observed in vitro using a 
titration of agonist peptides into fetal thymic organ cultures of NOD TCR transgenic cells, 
in which Treg cell numbers were positively related to peptide dose at low concentration, 
but diminished at high antigen concentration due to extensive negative selection [49]. 
This phenomenon was also replicated in vivo using intravenous peptide administration 
[42]. Finally, a recent study using transgenic mice in which the level of antigen 
presentation was decreased by the downmodulation of MHC class II expression in Aire-
expressing mTEC cells also showed a shift from negative selection to Treg cell 
development, which utilized a newly described transgenic of an Aire-promoter driven 
shRNA against C2TA, a master regulator of MHC class II expression (C2TA
kd
) [41]. 
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Thus, the experimental evidence favors a model by which Treg cell development is most 
efficient within an avidity window below that of negative selection. 
 While the current data provide a framework for understanding the role of avidity 
and affinity in thymic Treg cell selection, a number of questions remain. One potential 
issue is the use of transgenic lines in which there is only a single TCR clonotype. As 
discussed above, the efficiency of Treg cell development can be heavily influenced by the 
clonal frequency of the T cell [39, 40]. This complicates the interpretation of experiments 
that increase the amount of antigen level as a means to understand avidity. The traditional 
interpretation is that the increased number of ligands per APC leads to enhanced TCR 
signaling and Treg cell selection.  However, it may be possible that the increased amount 
of antigen results in more APCs with sufficient ligand, enhancing the frequency of 
Foxp3
+
 cells generated via an enlarged niche. Given that intraclonal competition also 
affects positive selection [50, 51], albeit to a lesser degree, it is reasonable to expect that 
negative selection is also affected by an antigenic niche.  Thus, the analysis of Treg cell 
differentiation versus negative selection may be quite different at high versus low clonal 
frequencies. 
 Another issue is the use of antigen-transgenic lines driven by ubiquitous 
promoters, peptide injection into mice, or addition of peptides to fetal thymic organ 
cultures (FTOC), which presumes that Treg cell selecting ligands are fairly ubiquitous 
and the APC environment of the thymus is monolithic. Experimental evidence suggests 
that Treg cell selection utilizes a limited antigen niche [39], making ubiquitous antigens 
less likely to model thymic Treg cell development. Moreover, the distribution of selecting 
ligand on the various thymic APC subsets may or may not represent that of natural Treg 
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cell ligands. For example, expression of antigen in the cortex might favor negative 
selection rather than Treg cell development. However, these data may still be relevant as 
the range of antigens that select thymic Treg cell development has yet to be fully 
explored. Thus, although the current data show that affinity and avidity play important 
roles in thymic Treg cell selection as proof of principle, future experiments will be 
required to understand in a quantitative fashion how reactivity to self-antigens dictates 
cell-fate choice between Treg cell differentiation, negative selection, and release from the 
thymus as an effector cell with autoimmune potential.   
 
A signaling threshold for thymic Treg cell development 
One reason that it has been difficult to address the role of self-antigen reactivity in 
Treg cell selection is the lack of effective in vivo assessment for TCR stimulation. While 
T cell activation markers such as CD69 and CD25 are associated with the process of Treg 
cell development [52], they did not provide compelling evidence due to their transient 
expression or their upregulation as a Treg cell marker, respectively. Recently, a new 
marker for TCR activation was reported using a Nur77 promoter driven GFP which 
revealed several interesting aspects of thymic Treg cell differentiation [43].  In a 
polyclonal population, they found that GFP expression was high on Foxp3
+
 compared 
with Foxp3
–
 cells, confirming the notion that Treg cells underwent TCR mediated 
selection to agonist ligand.  
 More instructive, however, was the analysis of Nur77-GFP in G113 Treg TCR 
transgenic cells that were known to be restricted by a small developmental niche [39]. 
One prediction was that intraclonal competition would result in a downward shift of a 
11 
 
monophasic TCR signal measured by Nur77-GFP, thereby decreasing the proportion in 
the "avidity" window of Treg cell development. However, what was observed was that 
G113 cells existed in a biphasic plot with distinguishable Nur77-GFP
hi
 and 
lo
 populations, 
which shifted in proportion depending on the clonal frequency of G113 thymocytes. 
Assuming that the Treg cell differentiation program itself does not affect Nur77-GFP 
levels, these data suggest that intraclonal competition operates by limiting the number of 
T cells obtaining a high level TCR signal, rather than decreasing the probability that a 
lesser TCR signal leads to Foxp3 induction. Niche size would then reflect the number of 
APCs that have sufficient antigen in terms of both affinity and avidity to induce "high 
level" TCR signaling, which remains to be biophysically defined in the context of Nur77-
GFP. Thus, this suggests that Treg cell differentiation is dependent on a certain threshold 
of TCR signaling, arguing for a "digital," rather than "analog" interpretation of TCR 
signals for thymic Treg cell development.  
 
Timing of thymic Treg cell differentiation: APC subsets 
The notion that self-antigen specificity selects the thymic Treg cell population 
engenders the question of which APCs are presenting what self-antigens. For example, it 
is known that cTEC and mTEC present different antigenic repertoires due to the use of 
distinct antigen processing enzymes [53]. Moreover, Aire expression in mTECs has been 
shown to induce the expression of tissue-specific antigens in the thymus [54]. Other 
differences between APCs such as co-stimulation may also affect thymic Treg cell 
differentiation. Thus, it is important to understand the contribution of the various thymic 
APC subsets in the generation of the thymic Treg cell population.   
12 
 
 Initial studies suggested that a normal frequency of CD25
+
 Treg cells can be 
generated when MHC class II is exclusively expressed in the cortex of the thymus [55]. 
Consistent with cortical Treg cell development, some studies showed a considerable 
frequency of Treg cells at CD4
+
CD8
+
 (DP) stage [56, 57]. However, other studies favor 
the notion that Treg cell differentiation mainly occurs at the CD4SP stage [58, 59]. The 
temporal analysis of Treg cell generation during the neonatal period as well as in young 
adults using neonatal bone marrow injection demonstrated that DP cells expressing 
Foxp3 are rare and the development of Foxp3
+
 cells mostly starts at immature CD4SP 
stage. Although a quantitative assessment of the relative contribution of cortical versus 
medullary APCs to thymic Treg cell differentiation is not established, it appears that most 
Treg cells are generated in the medulla.   
In this thesis, I examined intrinsic and extrinsic factors for Treg cell development 
in the thymus using TCR repertoire analysis, the affinity of TCR for self-antigen and 
APC environment determining the developmental stage of Treg cells respectively. First, 
in the study of TCR affinity, I demonstrated that thymic Treg cell development is directly 
correlated with TCR affinity to self-antigen in a broad range. Second, I observed that 
foreign antigen specific Treg cells can be generated by recognition of self-antigen via 
presumably promiscuous antigen presentation by thymic APCs. Third, it was suggested 
that high TCR affinity expands the number of APC delivering a Treg cell inducing signal. 
Last, I found that the threshold for peripheral T cell responses is well above that for 
thymic Treg cell development and correspond to that for negative selection, suggesting 
that thymic tolerance mechanisms are developed to accompany escaping self-reactive 
effectors with Treg cells to prevent autoimmune responses in the periphery. Also, in the 
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study of developmental period of Treg cells, I demonstrated that the frequency of Treg 
cells generated at DP stage is much smaller than previously suggested, and most Treg 
cells differentiate at immature CD4SP stage, implying an important role of medullary 
APC in facilitating efficient induction of Foxp3. Taken together, this dissertation study 
suggests that Treg cell development is a default outcome of self-antigen encounter of 
CD4 SP thymocytes, and TCR affinity for self-antigen instructs Treg cell development.  
14 
 
Chapter 2 
Tuning of thymic Treg cell selection to the self-reactive peripheral immune response 
 
Introduction 
The adaptive immune system generates a diverse array of antigen receptors to 
allow recognition of a variety of pathogens. However, a consequence of this diversity is 
that some receptors will recognize self with the potential to cause autoimmunity. For T 
cells, the issue of self-reactivity is mitigated as development occurs in a specialized organ, 
the thymus, where the immature T cell population is educated to the self-antigenic 
repertoire prior to their release into the periphery as mature T cells with the ability to 
cause autoimmunity. One important mechanism of education is the deletion of self-
reactive T cells, also known as negative selection [12, 13]. However, not all self-reactive 
thymocytes are eliminated, and some escape the thymus as effector cells with the 
potential to cause autoimmunity [15, 16].  A second mechanism of education to self-
antigens is now recognized to be the differentiation of self-reactive thymocytes to 
become Treg cells that suppress, rather than induce, inflammatory responses.   
TCR specificity was initially thought to be important for thymic Treg cell 
development as it was observed that TCR transgenic mice on a Rag-deficient background 
do not have Treg cells [20, 60], implying that only certain TCRs can facilitate Treg cell 
differentiation. Subsequent studies of TCR and antigen double transgenic mice suggested 
that recognition of self-antigen was the pertinent requirement for thymic Treg cell 
induction [60, 61]. Other reports using fetal thymic organ cultures (FTOC) and in vivo 
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peptide injection have supported this model [42, 49]. Taken together with other 
studies[36, 39, 40], the preponderance of the data suggests that self-recognition is an 
important requirement for thymic Treg cell selection. 
While these studies provide proof of principle that self-reactivity is required to 
trigger thymic education via Treg cell differentiation and negative selection, a number of 
questions remain.  First, many studies modeled interactions with ubiquitous antigens via 
transgenic expression or peptide administration in vivo or in vitro [42, 49]. However, 
recent data suggests that thymic Treg cell development utilizes a limited antigenic niche 
[39, 40], implying that ubiquitous antigen presentation may not be an appropriate model. 
Thus, the level of self-reactivity that elicits thymic education mechanisms for CD4
+
 T 
cells to tissue-specific antigens is unknown.   
Second, the study of TCR transgenic cells at high clonal frequencies may not 
represent what happens during normal thymic development, which occurs at very low 
clonal frequencies. For example, high clonal frequencies have recently been shown to 
markedly decrease the efficiency of thymic Treg cell development, presumably due to 
intraclonal competition [39, 40]. Thus, it may be possible that Treg cell development or 
negative selection may be different at high versus low clonal frequencies.  
Finally, while there have been studies of MHC class I restricted T cells regarding 
thresholds of negative selection [16, 62], the range of TCR self-reactivities that elicit 
thymic tolerance mechanisms in CD4
+
 T cells in vivo has not been examined. In some 
studies, the level of self-reactivity required to trigger thymic Treg cell differentiation has 
been suggested to be quite high [41, 61], being at or near the level of self-reactivity that 
induces negative selection. Moreover, thymic Treg cell differentiation may be dependent 
16 
 
on a certain threshold of TCR affinity for antigen, as Treg cell development was not 
observed with low affinity interactions, even if the antigen was expressed at high enough 
levels to induce negative selection [63]. On the other hand, it was reported that there was 
great overlap between the Treg and non-Treg TCR repertoires [37], suggesting that a 
broad range of self-reactivity, perhaps including TCRs that recognize self at the level of 
positive selection, was sufficient for Treg cell development. Also, direct demonstration of 
natural Treg TCR recognition of self-antigens presented on thymic APCs has not been 
successful [37], suggesting that the antigen is rare or that the TCR affinity for antigen is 
low. Determining the self-reactivity thresholds for thymic Treg cell induction and 
negative selection would be useful for understanding how the immune system perceives 
the problem of self-recognition and utilizes thymic education to control it. Thus, the 
quantitative level of self-reactivity that triggers thymic education mechanisms, and how 
that relates to level of self-reactivity required for peripheral immune responses, are not 
known.  
To address this question, I decided to fix the level of self-antigen and vary the 
efficiency of TCR recognition. Since natural Treg ligands are currently unknown, I 
utilized as a well-characterized model of a tissue-specific antigen, the RIP-mOVA 
transgenic line, in which the rat insulin promoter drives the expression of membrane 
bound ovalbumin (OVA) [64]. The developmental effects of thymic encounter with a 
relatively rare "self-antigen" can then be assessed at low clonal frequencies of T cells 
expressing a panel of naturally occurring TCRs with varying reactivity to OVA323-339 
identified from DO11 TCR transgenic mice. Remarkably, I observed a direct correlation 
between the degree of antigen-reactivity and thymic Treg cell generation over a broad 
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~1,000-fold range.  Negative selection was apparent with the more self-reactive TCRs.  
Finally, peripheral responses as measured by proliferation of naive T cells after transfer 
into irradiated RIP-mOVA mice required a degree of OVA-reactivity that induces both 
thymic negative selection and Treg cell development. Thus, these data demonstrate that 
the level of self-reactivity plays a crucial instructive role in thymic Treg cell 
differentiation, which is tuned to be substantially below the threshold for peripheral 
immune responses to self-antigen.   
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Materials and Methods 
1. Mice  
Foxp3
gfp
 mice [65] were a kind gift from A. Rudensky (MSKCC).   RIP-mOVA 
[64] mice Were obtained from Jackson Labs. DO11.10 TCRβ transgenic mouse line [66] 
was kindly provided by K. Murphy (Washington U.). All mice were backcrossed onto 
B6.C (B6 background congenic at the MHC locus with BALB/c) to facilitate breeding to 
mutant mice of B6 background, and were bred to generate DO11.10 TCRβ transgenic 
Foxp3
gfp
 TCRα+/– RIP-mOVA mice for TCR analysis. CD45.1 RIP-mOVA mice were 
also generated on the B6.C background.  Mice were housed in a specific pathogen–free 
animal facility and were used according to protocols approved by the Institutional 
Animal Care and Use Committee at Washington University.  
 
2. Reagents 
The following monoclonal antibodies were from eBioscience, Biolegend and BD 
Pharmingen: antibody to CD4 (RM4-5), anti-CD8 (53-6.7), anti-CD45.1 (A20), anti-
CD45.2 (104), anti-Thy-1.1 (HIS51), anti-CD25 (PC61), anti-HSA (M1/69), and anti–
TCR Vβ8 (F23.1). Chicken ovalbumin (OVA323-339) peptide (ISQAVHAAHAEINEAGR) 
was purchased from GenScript Corp. CFSE, Cell-Trace Far-Red DDAO dye and Cell-
Trace Violet Proliferation kit were purchased from Invitrogen. Recombinant mouse IL-3, 
recombinant human IL-6, and recombinant mouse stem cell factor for the bone marrow 
culture were obtained from Peprotech.  
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3. Culture of T cells and TCR sequencing 
Peripheral spleen and lymph node cells from DO11.10 TCRβ x Foxp3gfp Tcra+/– 
RIP-mOVA
–
 or 
+
 mice were labeled with DDAO and cultured with 1μM of OVA323-339 
for 5 days. DDAO low-Vβ8+ CD4 T cells were purified from Foxp3– and Foxp3+ subsets 
by FACS (FACSAria, Becton Dickenson). Sequencing and analysis of TRAV14 TCRα 
(Vα2) chains was performed as previously described [33].   
 
4. Measurement of EC50.   
For NFAT activation assay, T cell hybridomas expressing DO11 TCRβ, mCD4, 
and an NFAT-GFP reporter [66], were retrovirally transduced with TCRα. FACS sorted 
mCD4
+
Vβ8+Vα2+ cells were cultured with flt3 ligand-activated CD11+ APC and various 
concentrations of OVA 323-339. GFP expression was measured by flow cytometry 40 hrs 
post stimulation.  The NF-κB reporter cell line was generated by retroviral transduction 
of NF-κB-GFP construct [67] provided by B. Sleckman, Washington U., into DO11 
TCRβ-mCD4 T cell hybridomas, and then transduced with TCRα chains.  In these assays, 
the TA3 B cell hybridoma was used for APC to decrease background.  To measure IL-2 
production, 5KC T cell hybridomas expressing DO11β were transduced with a TCRα 
chain, and cultured with TA3 APCs.  The supernatants were assessed for IL-2 using a 
CTLL-2 bioassay with Alamar blue (Arcus biologicals).  
Thymic and peripheral T cells expressing an individual OVA peptide-specific 
TCR were generated by retroviral bone marrow chimeras as described below. 
Thymocytes were separated into CD4SP and DP subsets by magnetic cell purification 
using biotinylated anti-CD8 antibody and anti-biotin microbeads (AutoMACS, Miltenyi 
Biotec). CD4SP Were cultured with irradiated splenic APC pulsed with OVA323-339 to 
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measure CD25 induction at 24 hours by flow cytometry.  DP cells were also cultured 
with APCs to measure down regulation of CD4 and CD8 at 48hrs by flow cytometry.  
Pooled spleen and lymph node cells were labeled with CFSE and cultured with OVA323-
339.  Cell division of retrovirally transduced cells (CD45.2
+ 
CD45.1
– 
TCRβ+ Vα2+ CD4+) 
was assessed by flow cytometry after 72 hours.  To generate the dose response curve of 
each TCR, the activation/expression level at each concentration of peptide was 
normalized to that of anti-CD3 antibody (1µg/ml) stimulation, and EC50 was determined 
by nonlinear regression using GraphPad software. 
 
5. Tetramer binding 
T cell hybridomas (2x10
5
) expressing individual TCRs were stained with 20μg/ml 
of PE labeled tetramers of I-A
d
 protein with linked DO11 OVA epitope [68] at 37°C for 
90 min in round bottom 96-Well plates, and were further incubated with 2μg/ml of anti-
TCRβ antibody at 4°C for 30 min. Tetramer binding to TCRs was measured by MFI of 
PE using flow cytometry. 3K:I-A
b
 tetramer was used as a control.  
 
6. Retroviral transduction of TCR into CD4–CD8– thymocytes 
 Thymocytes from Foxp3
gfp
Rag1
-/-
 mice were transduced with MigR1-derived 
retroviruses expressing TCRα-P2A-DO11 TCRβ IRES-Thy1.1 as described  [69, 70]. 
One million cells in 10μl PBS was injected into the thymic lobe of sublethally irradiated 
(600 rads) wild-type and RIP-mOVA recipients. Development of Foxp3
+
 thymocytes was 
analyzed by flow cytometry 2 weeks later.  
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7. Retroviral bone marrow chimeras 
Generation of retroviral bone marrow chimeras have been previously described 
[39]. Here, I used Foxp3
gfp
Rag1
–/–
 B6.C mice as bone marrow donors, which were at 
times mixed with bone marrow of CD45.1 Foxp3
gfp
 mice at ratios of 1:0, 1:1 or 1:4, prior 
to injection (5x10
6
 total cells) into lethally irradiated (1,000 rads) CD45.1 wild-type or 
RIP-mOVA hosts.  Thymic and peripheral T cells were used for experiments or analyzed 
by flow cytometry 6 weeks later.   
 
8. Assessment of negative selection in vivo 
Thymocytes expressing individual TCRs were generated by retroviral bone 
marrow chimeras (not mixed) in wild-type hosts. CD4SP cells were FACS sorted, and 
mixed with Cell Trace Violet-labeled polyclonal thymocytes at a 1:1 ratio. CD4SP cells 
were injected into the thymus of either CD45.1 wild-type or RIP-mOVA recipients, and 
analyzed by flow cytometry on day 3 post transfer.  
  
9. Assessment of peripheral responses to antigen in vivo 
Peripheral CD4
+
 T cells expressing individual TCRs were generated by retroviral 
bone marrow chimeras in wild-type hosts, and labeled with Cell Trace Violet as a CFSE 
analog to follow cell division.  Foxp3
–
 CD4
+
 T cells (10
5
) were intravenously transferred 
into irradiated (500 rads) CD45.1 wild-type or RIP-mOVA recipients. Splenocytes were 
analyzed for proliferation and Treg cell conversion 14 days later by flow cytometry.  
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Chapter 2.1 
Identification of OVA peptide-specific TCRs in a broad range of affinity 
 
Results 
Identification of naturally occurring OVA323-339 peptide-specific TCRs 
The degree of self-reactivity that triggers thymic Treg cell differentiation of CD4
+
 
T cells is unknown, with studies favoring high [63] versus low [37] thresholds of self-
reactivity. As different thresholds for thymic Treg cell development may be predicted to 
generate different models regarding how self-reactive Treg and effector cells participate 
in immune responses to self- and foreign antigens in the periphery (Figure 2.1A,B), I 
sought to define this threshold using a panel of TCRs with varying self-reactivity. 
Although mutagenesis has been used to generate TCRs with different affinity to antigen, I 
decided to identify naturally rearranged OVA-reactive TCRs from the peripheral CD4
+
 T 
cell population to avoid non-physiologic TCR interactions with peptide:MHC molecules. 
As the frequency of OVA-specific T cells in the normal T cell population is very low, I 
reasoned that using a TCR β-transgenic line from an OVA-specific TCR would  increase 
the precursor frequency based on observations from the MHC class I restricted OT-I 
transgenic line [71]. Another advantage of fixing the TCR β-chain is that the physical 
framework for TCR recognition of peptide:MHC molecules will be similar between 
different TCR α-chains. I therefore obtained a TCR β transgenic line based on the 
DO11.10αβ TCR [66], which recognizes OVA323-339 peptide at agonist level affinities [72, 
73]. To ensure that only one TCR α chain is expressed per cell, the mice were bred to be 
23 
 
Tcra
+/–
. Thus, I used DO11β Foxp3gfp B6.C (H-2d) Tcra+/– RIP-mOVA+ or – mice as a 
source of T cells to identify a panel of OVA-specific TCRs (Figure. 2.2A).   
To enrich for OVA-specific TCRs amongst the TCR β transgenic polyclonal 
repertoire, I identified T cells that proliferated after in vitro stimulation with OVA 
peptide using dilution of DDAO, a cellular dye similar to CFSE but compatible with GFP 
(Figure 2.2B). However, there appeared to be substantial OVA-independent proliferation.  
To identify OVA-specific TCRs, I looked for TCR sequences that were enriched in the 
OVA-stimulated versus un-stimulated T cell populations.  I obtained 3,785 TCRα 
sequences from Foxp3
+
 and Foxp3
–
 cells from RIP-mOVA
+
 or 
–
 mice stimulated in vitro 
with or without OVA-peptide (Figure 2.2C). I restricted the initial analysis to the 
TRAV14 (Vα2) repertoire to limit the possible structural configurations of TCR 
interaction with OVA peptide:MHC II molecules. As expected, there was substantial 
overlap between the OVA stimulated and un-stimulated repertoires (Figure 2.3). In 
particular, the 9 most frequent Foxp3
-
 TCRs on T cells from RIP-mOVA
+
 mice were 
found at comparable frequencies irrespective of OVA-peptide stimulation, suggesting 
that the precursor frequency of OVA-specific cells is much lower in these mice due to 
negative selection.  
In order to confirm OVA-peptide specificity, I selected the most frequent TCRs 
found in the OVA but not control cultures (highlighted in grey, Figure 2.3) and expressed 
them on DO11β T cell hybridoma lines that contain GFP driven by NFAT as a reporter 
for TCR stimulation [66]. Since the parent line prior to retroviral transduction was the 
same, the hybridoma cells should differ only by the TCRα sequence, allowing direct 
comparison of antigen recognition regardless of the cellular source of the TCR. However, 
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only a subset of these TCRs showed reactivity to OVA peptide presented by Flt3L 
induced dendritic cells (Figure 2.4), suggesting that low frequencies and well to well 
variability limited the effectiveness of this subtraction approach.   
In these screening experiments, I noted that the only TCRs which exhibited OVA-
reactivity, regardless of T cell subset or RIP-mOVA status, utilize TRAJ21 (Jα21), which 
happens to be the same J-region utilized by the TRAV5D (Vα13) DO11αβ-chain. This 
suggests that Jα21 provides structural features that facilitate recognition of OVA-peptide 
in the context of DO11β. I therefore identified all naturally rearranged Jα21 containing 
TCRs in our data set irrespective of frequency, T cell subset, or genotype, and tested 
them for OVA-reactivity (Figure 2.5). Interestingly, only TCRs with a CDR3 length of 10 
showed reactivity to OVA. Thus, I have identified a panel of 8 naturally arising TCRs all 
with Jα21 and the same CDR3 length that recognize OVA-peptide:MHC class II I-Ad 
(Figure 2.6), suggesting that these TCRs all recognize in a very similar manner OVA323-
339 bound to I-A
d
 in a single register. 
 
The panel of TCRs exhibit a broad range of reactivity to OVA 
To calculate the efficiency of OVA recognition, I determined the effective 
concentration of OVA peptide that elicited half-maximal responses (EC50) for each TCR 
using non-linear regression analysis (Figure 2.7A).  As an inter-experiment control, the 
peptide responses were normalized to that of anti-CD3 antibody treated cells.  Since the 
EC50 is dependent on the functional characteristics of the assay, I decided to use DO11αβ 
as a reference TCR for a typical agonist level response to foreign antigen.  Thus, the 
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relative efficiency by which a TCR recognizes OVA peptide in comparison with DO11 is 
denoted as Log(EC50) = Log(EC50 DO11) - Log(EC50 TCR). 
The first quantification of the efficiency of OVA recognition utilized the NFAT-
GFP reporter hybridoma cells generated for the initial functional screening above (Figure 
2.6). I observed that our TCRs spanned over 3 logs in relative EC50 to our reference TCR 
DO11, with TCRs N7 and N9 within 1 log of DO11, R1/R4 within the 2
nd
 log, and R2, 
N12, N13 and P1 with even lower reactivity to OVA.  Note that changes in one or two 
amino acids greatly affected the recognition of OVA, such that P1 exhibits greater than a 
thousand fold-lower sensitivity to peptide antigen than DO11.10, although there may also 
be effects in the CDR1/2 regions for R2 and N9 (Figure 2.6A). Thus, I have identified a 
panel of 8 TCRs that recognize OVA with a broad range of efficiencies. 
 
Thymic Treg cell selection of TCRs with foreign antigen-reactivity 
I first wanted to establish that our panel of OVA-reactive TCRs does not facilitate 
thymic Treg cell development in the absence of OVA, which would preclude 
straightforward interpretation of OVA-dependent Treg cell generation.  I utilized 
retroviral transduction of DN thymocytes followed by intrathymic transfer into 
congenically marked hosts [69, 70] to assess the development of Foxp3
+
 cells 2 weeks 
after transfer.  I did not observe Treg cell development in T cells expressing the DO11 
TCR, as well as five OVA-reactive TCRs (Figure 2.7B).  Interestingly, there were three 
TCRs which facilitated thymic Treg cell development in the absence of OVA, suggesting 
that these TCRs may recognize unknown self-antigens for Treg cell selection.  This is 
further supported by the observation of R1 and R2 in the Treg TCR repertoires from 
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wild-type mice (Figure 2.3). It appears that both TRAV14 subtype and CDR3 sequence 
affects this presumed self-reactivity, as R2 and N9 use the same TRAV14 subtype but 
different CDR3 sequence, whereas R1 and R2 utilize the same CDR3 sequence, but have 
different TRAV regions.  Thus, these data demonstrate that it is possible to generate Treg 
cells in the thymus that also recognize foreign antigens, presumably due to the 
promiscuity of TCR recognition.   
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Figure Legends 
 
Figure 2.1. Hypothetical models on the relationship between thresholds for thymic 
Treg cell selection and peripheral tolerance and immunity.   
(A) High threshold of self-reactivity model for thymic Treg cell selection.  Self-
reactive TCRs above a high threshold are selected into Treg cells, which prevent 
autoimmunity elicited by lower affinity T cells.  In this model, there is no selection of 
Treg cells to foreign antigens, allowing effector T cells to efficiently respond to foreign 
antigens. Blue circles represent self-reactivity at the level of positive selection, and 
maroon circles self-reactivity at varying levels as indicted by the darkness of the fill color. 
Treg cells are indicated in shades of green fill color.  (B) Low threshold of self-reactivity 
model.  In this model, a broad repertoire of Treg cells is generated with low correlation to 
self-reactivity.  Tolerance to self occurs as Treg cells are generated to most antigen-
specificities.  However, Treg cells will also be generated to foreign antigens, and has 
been proposed to prevent excess immunopathology that can be occurred during immune 
responses to pathogens.  (C) Our data suggest that thymic Treg cell generation is best 
represented by an intermediate model as it is directly driven by self-reactivity over a 
broad range, but is above the level of positive selection.  In this model, foreign antigen-
reactive thymic Treg cells arise due to incidental self-reactivity of the TCR, presumably 
related to promiscuous antigen recognition. For negative selection, the shape of the curve 
is not known (indicated by dashed line and ?). For positive selection, the range of 
affinities is not well established (indicated by dashed line). Int., intermediate.  
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Figure 2.2.  TCR sequencing of OVA peptide-reactive T cells   
(A) Flow cytometry of the thymic and splenic CD4
+
 T cells from DO11β Foxpgfp 
Tcra
+/–
 RIP-mOVA
–  or +
 mice. (B) Gating scheme for sorting of proliferating cells after in 
vitro activation with OVA-peptide.  DDAO is a dye analogous to CFSE that is used to 
determine cell division.  The percentage of cells in each quadrant is indicated by the 
number.  Boxes with dashed lines represent the gates used to sort proliferating Foxp3
–
 or 
Foxp3
+
 cells. (C) Numbers of TCRs sequenced from the sorted cell populations indicated 
in (B). Each experiment represents pooled spleen and lymph nodes from 2 mice.  TCR 
sequence database was generated by pooling sequences from all experiments.   
 
Figure 2.3.  Selection of possible OVA peptide-reactive TCRs using repertoire 
analysis 
 The 20 most frequent TCRs are shown for Foxp3
+
 and Foxp3
–
 cell subsets from 
RIP-mOVA
– or +
  mice (numbers in blue). TCRs found only in the OVA peptide culture 
were presumed to be OVA reactive and cloned for functional screening using hybridoma 
cells (highlighted in grey). TRAJ21 TCRs are shown in red.  Note that R1* and R2** 
TCRs of the same CDR amino acid sequence are distinguished by usage of polymorphic 
TRAV14-3*01 and TRAV14D-1*01, respectively.  Numbers in the table represent the 
frequencies of the TCR in each subset.    
 
Figure 2.4. Confirmation of OVA peptide-reactivity  
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TCRs selected from the repertoire analysis in Figure 3 were retrovirally expressed 
on the NFAT-GFP reporter hybridoma line.  TCRs selected from Foxp3
–
 RIP-mOVA
–
 
cells were also tested, but did not have any OVA-reactive TCRs not shown above.  TCRs 
that contain TRAJ21 sequence in their CDR3 are shown in red as Supplementary Figure 
3.  One TRAJ21 TCR did not show reactivity to 1 mM OVA peptide in vitro (†), and one 
did not express in vivo in the TCRα-P2A-DO11β vector for unknown reasons (‡). These 
two TCRs were therefore not studied further. Data are representative plots from two 
independent experiments.  
 
Figure 2.5. Screening of TRAJ21 containing TCRs 
(A) Summary of all TRAJ21 TCRs found in our TCR database. TCRs that 
induced NFAT-GFP expression are highlighted in grey with differences in amino acid 
sequence marked in red.  (B) Flow cytometry of NFAT-GFP expression by TCRs in (A). 
Data are representative plots from two independent experiments.        
 
Figure 2.6. TCRs exhibit a broad range of reactivity to OVA peptide.  
(A) Summary of sensitivity to OVA-peptide for 9 TCRs including DO11. 
Sensitivity to OVA-peptide was determined using an NFAT-GFP hybridoma as discussed 
in Figure 7A.  (B) Flow cytometric plots of NFAT-GFP expression by hybridoma cells 
expressing OVA-reactive TCRs in (A) after stimulation with Flt3L-induced DCs and 1 
mM OVA peptide. (C) Expression levels of retrovirally transduced TCRs on hybridoma 
cells. Data are representative from three independent experiments. 
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Figure 2.7. In vitro and in vivo analysis of OVA-reactive TCRs   
(A) In vitro assessment of TCR sensitivity to OVA peptide.  NFAT-GFP reporter 
hybridomas expressing each of 9 TCRs, including DO11 (red), was generated via 
retroviral transduction of TCRα chains, and tested against a range of OVA peptide 
concentrations presented by Flt3L induced dendritic cells.  Data shown are the frequency 
of NFAT-GFP
+
 cells normalized to that of αCD3 antibody treated cells for each 
hybridoma line.  Data are representative of three independent experiments. (B) In vivo 
assessment of thymic Treg cell development.  Double-negative (DN) thymocytes from 
Foxp3
gfp
Rag1
–/–
 were retrovirally transduced with each OVA-specific TCR and 
transferred into the thymus of wild-type mice, and analyzed for Treg cell generation 14-
days post transfer.  Data are representative of 3-4 mice for each TCR from at 2 
independent experiments. 
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Figure 2.1. Hypothetical models on the relationship between thresholds for thymic 
Treg cell selection and peripheral tolerance and immunity.  
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 RIP-mOVA– RIP-mOVA+ 
 no peptide OVA323-339 no peptide OVA323-339 
 Foxp3– Foxp3+ Foxp3– Foxp3+ Foxp3– Foxp3+ Foxp3– Foxp3+ 
Expt. 1 50 127 114 72 101 132 120 124 
Expt. 2 55 100 108 129 135 117 105 101 
Expt. 3 117 84 122 162 120 163 208 131 
Expt. 4 119 142 99 121 128 137 112 130 
Total  No. 
Sequences 
341 453 443 484 484 549 545 486 
 
 
 
 
 
Figure 2.2.  TCR sequencing of OVA peptide-reactive T cells    
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Figure 2.3.  Selection of possible OVA peptide-reactive TCRs using repertoire 
analysis   
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Figure 2.4. Confirmation of OVA peptide-reactivity  
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Figure 2.5. Screening of TRAJ21 containing TCRs   
Vα2 
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Figure 2.6. TCRs exhibit a broad range of reactivity to OVA peptide.  
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Figure 2.7. In vitro and in vivo analysis of OVA-reactive TCRs    
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Chapter 2.2 
A role of TCR affinity in thymic tolerance mechanisms and self-reactive peripheral 
immune response 
 
Results 
TCR affinity is a primary determinant for thymic Treg cell development  
To avoid the complication of OVA-independent Treg cell generation, I decided to 
focus on the 6 TCRs, including DO11, which did not facilitate thymic Treg cell 
development in wild-type mice.  The differences between the 5 TCRs are only in the 
CDR3 amino acid sequence, as all of these TCRs use the same TRAV14-3*01 subtype. 
Because measurement of OVA reactivity so far was based a single readout using the 
NFAT-GFP reporter, I sought to expand the analysis of functional responses to TCR 
stimulation.  I utilized another marker, NF-κB-GFP, which was introduced into the same 
parent hybridoma line used by NFAT-GFP [66].  Since this parent hybridoma line 
produced little IL-2, I tested IL-2 production after re-expressing these TCRs in a different 
TCR-deficient hybridoma line, 5KC-73.8.20 [74].  Although the range of measured EC50s 
varied from ~50-5,000 fold depending on the assay, the ordering of TCRs in terms of 
efficiency of OVA recognition remained mostly constant (Figure 2.8A, Table 2.1).   
Since TCR signaling may differ between hybridoma cells and primary T cells, I 
also assessed peptide reactivity using thymocytes and peripheral T cells. T cells 
expressing individual OVA peptide-reactive TCRs were generated using retroviral bone 
marrow chimeras using Rag1
–/–
 donors.  The EC50 for each TCR was determined in vitro 
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by assessing down-regulation of co-receptors CD4 and CD8 on CD4
+
CD8
+
 (double 
positive, DP) thymocytes, CD25 upregulation on CD4
+
CD8
–
 (CD4 single positive, 
CD4SP) thymocytes, and proliferation of peripheral CD4
+
 T cells (Figure 2.8B). Similar 
to the results obtained using hybridoma assays, the OVA-specific TCRs showed a broad 
range of sensitivity such that the least reactive TCR P1 was ~300-6,000 folds less 
efficient than DO11.10 at recognizing OVA (Table 2.1).  Thus, the data from 6 different 
hybridoma and primary T cell assays agree that these 6 TCRs exhibit a broad range of 
sensitivity for OVA recognition.  
To estimate the TCR affinity for peptide:MHC, I measured the mean fluorescence 
intensity (MFI) of equilibrium tetramer binding, which provides a relative assessment of 
monomeric TCR:pMHC affinity  [75-77].  Consistent with the functional assessment of 
OVA-reactivity, tetramer binding classified N7and R4 as higher affinity TCRs (Figure 
2.8C) in comparison with N12, N13, and P1, which showed little to no binding.  
Although the latter 3 TCRs can elicit in vitro responses to OVA-peptide, these TCRs are 
below the affinity range that can be quantified using this tetramer binding assay.  Thus, 
these tetramer data suggest that this panel of TCRs recognize OVA peptide:MHC with a 
broad range of affinities. 
I next assessed the ability of thymic OVA expression via RIP-mOVA to induce 
thymic Treg cell development using retroviral transduction of TCRs into Rag1
–/–
 
thymocytes followed by intrathymic transfer as described above.  As expected, DO11 
facilitated thymic Treg cell development in the presence of RIP-mOVA [78].  
Interestingly, all of the other TCRs except for P1, the lowest-affinity TCR, induced Treg 
cells to a degree that varied with the efficiency of OVA recognition (Figure 2.9 A,B).  
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Treg cell generation could even be detected in cells expressing the low affinity TCRs 
N12 and N13, which could not be reliably measured by equilibrium tetramer binding, and 
require ~1200 fold (average of responses in 6 assays between P1 and DO11 in Table 2.1) 
more antigen to achieve the same response in comparison to DO11.  However, I was 
unable to observe Treg cells generated by P1, which is very close to N13 in its sensitivity 
to OVA.  Although stochastic expression of RIP-mOVA in thymic mTEC cells may 
contribute to mouse to mouse variability [79], differences between TCRs were readily 
observed. Thus, these data show that TCRs which are on average one hundred to one 
thousand fold less sensitive than DO11 can generate thymic Treg cells, demonstrating 
that Treg cell differentiation can occur within a broad range of self-reactivity.   
Linear regression analyses for all assays revealed that the ability of TCRs to 
facilitate Treg cell generation is directly proportion to their affinity for OVA peptide as 
provided by RIP-mOVA (Figure 2.9C).  The efficiency of self-recognition was also 
directly correlated with the generation of Foxp3
–
CD25
+
 cells (Figure 2.9D,E), consistent 
with the proposal that the process of thymic Treg cell generation occurs via TCR-
dependent generation of Foxp3
–
 Treg precursor cells [52]. Thus, these data demonstrate 
that the degree of self-recognition is the primary determinant for Treg cell differentiation 
in the thymus. 
 
Treg cell selection niche is dependent on TCR affinity for self-antigen  
Thymic Treg cell selection utilizes a small "niche" based on the observation of 
intraclonal competition in studies of transgenic mice using naturally arising Treg TCRs 
[39, 40]. Since the natural ligands for these Treg TCRs are unknown, the factors that 
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affect this developmental niche are unknown.  I therefore asked whether affinity to self-
antigen affects the size of the Treg cell developmental niche.  Since the intrathymic 
transfer of retrovirally transduced thymocytes does not assess Treg cell generation at 
steady state, I decided to analyze retroviral bone marrow chimeras using the two highest 
affinity TCRs along with DO11.  Various ratios of congenically marked wild-type bone 
marrow was added to achieve varying clonal frequencies.  I confirmed that these OVA-
reactive TCRs did not facilitate Treg cell generation in wild-type mice, even at low clonal 
frequencies (Figure 2.10A).  Consistent with previous reports [39, 40], I observed that 
Treg cell development with all 3 TCRs was inversely correlated with clonal frequency in 
the presence of OVA peptide presentation (Figure 2.4A). Moreover, the efficiency of 
Treg cell generation was directly correlated with affinity, as evidenced by the ability of 
higher affinity TCRs to generate a higher frequency of Treg cells at a given clonal 
frequency (Figure 2.10B).  The affinity of the TCR also correlated with the absolute 
number of Treg cells that are generated in the thymus, implying that higher affinity TCRs 
have a larger niche size for thymic Treg cell development (Figure 2.10C,D).  Since the 
amount of antigen generated by the RIP-mOVA transgene should be equal between 
different bone marrow chimeras, I hypothesize that niche size in this case represents the 
number of APCs that present sufficient antigen to trigger Treg cell selection for a given 
TCR affinity.  
 
Threshold for negative selection  
Some studies using TCR transgenic models have reported negative selection to be 
coincident with Treg cell generation [32, 61], whereas other studies have suggested that 
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Treg cell selection may occur without obvious negative selection [39].  Thus, the level of 
self-reactivity requwered to elicit Treg cell differentiation versus negative selection 
remains poorly defined.   
An interesting observation from our studies of clonal frequency and Treg cell 
development was that the frequency of Treg cells using the higher affinity TCRs, DO11 
and N7, actually Int down again at clonal frequencies below 0.1% (red box, Figure 
2.10A).  This was not apparent for the intermediate affinity TCR R4, nor for other TCRs 
tested in previous reports [39], although it remains possible that this could be observed if 
loIr clonal frequencies could be achieved experimentally.  One possible explanation for 
this observation is that TCRs with high affinity to antigen can induce negative selection 
rather than Treg cell differentation at low clonal frequencies. In this case, the remaining 
Foxp3
–
 CD4SP cells have presumably have not yet encountered antigen.  
To test the hypothesis that negative selection to RIP-mOVA occurs with T cells 
expressing TCRs N7 and DO11, but not R4, I assessed whether purified CD4SP 
thymocytes from retroviral bone marrow chimeras in wild-type hosts would be deleted 
after intrathymic transfer into RIP-mOVA
+
 recipients.  At day 3 post-transfer, I observed 
that the relative ratio of thymocytes expressing the higher affinity TCRs DO11 and N7, 
but not R4, to the co-injected polyclonal thymocytes Were decreased in RIP-mOVA 
hosts, indicative of negative selection (Figure 2.11).  Consistent with previous reports 
[63], these data suggest that the propensity to induce Treg cell differentiation does not 
always rescue the cells from negative selection. Since R4 is approximately 15-fold 
(average of 6 assays, Table 2.1) less efficient at recognizing OVA than DO11, these data 
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suggest that detectable negative selection occurs at a substantially higher affinity 
threshold than Treg cell selection.   
 
Differential affinity thresholds for thymic Treg cell development and peripheral 
responses to self 
These studies in the thymus suggest that a broad range of TCR affinity can elicit 
Treg cell development, albeit at varying degrees. As the affinity for self-antigen 
decreases, the percentage of Foxp3
–
 conventional T cells emigrating from the thymus 
increases. Thus, understanding the relationship between the range of affinities that 
facilitate thymic Treg cell generation versus peripheral responses is important for 
clarifying the how self-reactive Treg cells may mediate self-tolerance in the periphery.  
To address this question, I adoptively transferred peripheral Foxp3
–
 CD4 T cells 
bearing OVA-reactive TCRs into sub-lethally irradiated RIP-mOVA recipients, as no 
proliferative responses were observed in non-irradiated mice. Intriguingly, the 
intermediate affinity TCR R4 or low affinity TCR N12 did not respond to OVA in vivo 
under these conditions (Figure 2.12 A, B).  By contrast, the higher affinity TCRs DO11 
and N7 induced peripheral expansion of Foxp3
–
 cells as well as a small amount of Treg 
cell differentiation (Figure 2.12 A, B). Consistent with previous observations [80], 
peripheral Treg cell generation occurred on cells with less proliferation (Figure 2.12 C).  
Interestingly, the affinity threshold for response to this peripheral self-antigen is similar 
to that of thymic negative selection, whereas the threshold for thymic Treg cell 
development is almost 100 fold lower (average R4 versus P1 sensitivity to OVA, Table 
2.1).  Thus, these data suggest a model where thymic Treg cell differentiation is tuned 
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such that T cells with sufficient self-reactivity to elicit peripheral immune responses 
cannot wholly escape the thymus as effector cells, and will always be accompanied by 
thymically generated Treg cells (Figure 2.1C).  
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Figure Legends 
 
Figure 2.8.  Defining efficiency of OVA recognition using hybridoma and primary T 
cells.  
(A) Hybridoma assays.  Hybridoma cells expressing OVA-specific TCRs were 
assessed for NF-κB-GFP expression (left) and IL-2 production (right) in response to 
varying amounts of OVA peptide presented by TA3 APCs.  (B) Assays of TCR reactivity 
using primary thymocytes and peripheral T cells.  T cells were obtained from retroviral 
bone marrow chimeras using wild-type hosts.  DP thymocytes were assessed for down-
regulation of CD4 and CD8 coreceptors in response to Flt3L DCs and varying 
concentrations of OVA peptide (left).  CD4SP thymocytes were tested for CD25 
upregulation (middle).  Finally, peripheral CD4
+
 T cells were tested for in vitro 
proliferation (right).  Non-linear regression analysis and calculation of EC50 was 
performed as per Figure 7a, and summarized in Table 2.1 as ∆EC50.  Graphs shown are 
representative of three independent experiments. (C) Binding of OVA:I-A
d
 tetramer to 
hybridoma cells expressing OVA-reactive TCRs. Representative plots are shown on the 
left, and summarized on the right (mean ± s.d., n=3 independent experiments).  3K:I-A
b
 
tetramer was used as a control.  
 
Figure 2.9. Thymic Treg cell generation is instructed by the level of TCR reactivity 
to self-antigen.  
(A) Flow cytometry of Treg cell generation by OVA-reactive TCRs in the 
presence of RIP-mOVA. Retrovirally transduced Rag1
–/–
 DN cells were transferred into 
thymus of RIP-mOVA mice, and were analyzed at 2 weeks as in Figure 2.7 B. (B) Data 
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in (A) are summarized, with each dot representing the frequency (left) and absolute 
number (right) of Foxp3
+
 cells from an individual recipient. The plot in the middle shows 
the mean Foxp3
+
 percentage (± S.E.M.) correlated with the Log(EC50) of the TCR for 
NFAT-GFP activation as compared with DO11. Foxp3
+
 cells were not detected (n.d.) 
with the P1 TCR.  (C) Correlation of Treg cell generation with in vitro sensitivity to 
OVA.  To determine whether TCR affinity is directly correlated with the efficiency of 
Treg cell selection in vivo, I plotted the in vivo efficiency of Treg cell generation versus 
the Log(EC50) of the TCR as compared with DO11, and analyzed it by linear regression. 
For tetramer binding, I used the Log(MFI) as compared with DO11. Each symbol 
represents an individual TCR indicated in the legend. (D) The frequency of Foxp3
–
CD25
hi 
CD4SP cells in the experiments described in (A) are shown (mean ± s.d., 5 
independent experiments).  (E) Correlation of Foxp3
–
CD25
hi 
CD4SP cells with sensitivity 
of TCR to OVA peptide.  Frequencies of Foxp3
-
CD25
hi 
cells shown in (D) were plotted 
as per (C).    
 
Figure 2.10. A role for TCR affinity in the thymic Treg cell selection “niche”   
(A) Inverse relationship between clonal frequency and thymic Treg cell 
development.  Thymic Treg cell development was assessed in mixed bone marrow 
chimeras with varying ratios of wild-type to retrovirally transduced bone marrow. Data 
shown are the percentage of Foxp3
+
CD4SP cells versus the clonal frequency in the 
CD4SP subset for the indicated TCR. Each symbol represents data from an individual 
recipient from 2-3 independent experiments for each TCR. Data points in the dashed red 
boxes fall outside of the previously described inverse relationship.  (B) Data from the 
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experiment shown in (A) are plotted log-log to illustrate the similar slopes, with 
differences in the intercept.  Note that the points in the red boxes are not shown in this 
plot.  (C) Absolute numbers of Treg cells from the data shown in (B) are plotted versus 
clonal frequency.  (D) Correlation of Treg cell selection niche size to TCR affinity. The 
number of Foxp3
+
 cells was analyzed by linear regression with OVA-reactivity measured 
by NFAT activation (left) and tetramer binding (right) as per Figure 2.9. Each symbol 
represents an individual TCR as indicated in the legend.  
 
Figure 2.11. Treg cell development coincident with negative selection by high 
affinity TCRs   
(A) Assessment of negative selection of CD4SP thymocytes. OVA-reactive 
CD4SP thymocytes and Cell-tracker violet labeled WT cells were intrathymically 
injected into wild-type and RIP-mOVA mice.  Flow cytometry was performed 3 days 
later. Representative FACS plots are shown discriminating the injected wild-type and 
OVA-specific CD4SP cells marked as blue numbers (left), and the TCR transduced 
population (right).  No Treg cells were observed in wild-type recipients for all TCRs 
tested (not shown). (B) Negative selection as assessed by the ratio of OVA-specific 
CD4SP cells to WT cells added as an injection control.  Each dot represents an individual 
recipient, with 2 independent experiments per TCR.  Statistical differences were accessed 
by unpaired t test. (C) Summary of negative selection experiment in (B).  The percent 
difference in the mean values from wild-type hosts compared with RIP-mOVA hosts is 
shown for each TCR.  
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Figure 2.12. High affinity TCR recognition of peripheral self-antigen is required to 
elicit peripheral T cell responses.  
(A) Assessment of peripheral T cells responses.  Naïve peripheral Foxp3
–
CD4
+
 T 
cells were intravenously transferred into sublethally irradiated RIP-mOVA hosts.  
Preliminary experiments did not reveal proliferation in non-irradiated hosts.  
Representative flow cytometry plots are shown of the transferred splenic T cells after 14 
days to determine proliferation via dilution of cell-tracker violet dye.  (B)  Summaries of 
frequencies of proliferated (left) and Foxp3
+
 (right) cells–see gating in (A).  Each dot 
represents data from a single recipient, with 2 independent experiments per TCR. (C) 
Peripheral conversion is inversely correlated with proliferation.  Dilution of cell-tracker violet is 
shown for Foxp3
+
 (dark line) and Foxp3
–
 (grey shading) cells.   
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† The relative sensitivity of OVA recognition is shown as the difference of Log (EC50) from that of DO11. 
‡ The relative affinities of TCRs are shown as the difference of Log (MFI) from that of DO11.  
Data shown are mean ± s.e.m. (n=3).   
Thymic selection is based on in vivo assays presented throughout the paper.  Neg., negative selection. Treg, 
Treg cell selection is observed.   
 
 
 
 
 
Table 2.1. Summary of assessments of TCR reactivity   
 
Clone 
CDR3 a.a 
Sequence 
Hybridoma† T cells† 
Tetramer 
binding‡ 
Thymic 
Selection NFAT 
activation 
NFκB 
activation 
IL-2 
production 
CD4/8 
on DP 
CD25 on 
CD4SP 
CD4 T cell 
proliferation 
DO AASPNYNVLY        Neg./Treg 
N7 AACPNYNVLY -0.2±0.2 -0.3±0.1 -0.1±0.1 -0.8±0.2 -0.9±0.6 -0.7±0.2 -0.30±0.03 Neg./Treg 
R4 AAVPNYNVLY -1.2±0.5 -0.5±0.2 -0.7±0.2 -0.9±0.1 -1.6±0.6 -1.3±0.5 -0.84±0.04 Treg 
N12 ATTPNYNVLY -2.6±0.2 -1.3±0.5 -1.5±0.3 -1.7±0.2 -2.3±0.7 -2.1±0.6 ≤-1.30±0.05 Treg 
N13 AASKNYNVLY -3.5±0.2 -1.6±0.3 -2.2±0.4 -2.0±0.2 -3.0±0.9 -3.8±0.3 ≤-1.35±0.04 Treg 
P1 AAPPNYNVLY -3.7±0.3 -1.7±0.3 -2.7±0.2 -2.5±0.3 -2.1±0.5 -3.0±0.4 ≤-1.34±0.05 Tconv 
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Figure 2.8.  Defining efficiency of OVA recognition using hybridoma and primary T 
cells   
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Figure 2.9. Thymic Treg cell generation is instructed by the level of TCR reactivity 
to self-antigen.  
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Figure 2.10. A role for TCR affinity in the thymic Treg cell selection “niche”   
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Figure 2.11. Treg cell development coincident with negative selection by high 
affinity TCRs   
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Figure 2.12. High affinity TCR recognition of peripheral self-antigen is required to 
elicit peripheral T cell responses. 
C 
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Discussion 
Although previous studies provided proof of principle that self-reactivity is an 
important factor for thymic Treg cell differentiation and negative selection, there was 
little sense of how much self-reactivity is required at low clonal frequencies.  
Quantification of the relationship between self-reactivity and thymic Treg cell selection is 
important for understanding how thymic Treg cells may provide tolerance in the 
periphery. A high threshold of self-reactivity for Treg cell differentiation [63] would 
predict that many low-affinity self-reactive T cells would escape the thymus as effector 
cells, relying primarily on the presence of high affinity self-reactive Treg cells to provide 
tolerance. By contrast, a low threshold of self-reactivity for Treg cell differentiation 
would broaden the Treg cell repertoire such that it may almost approximate that of the 
effector cell repertoire [37], increasing the likelihood that thymic Treg cells will 
participate in not only immune responses to self, but also non-self antigens. Thus, 
understanding the relationship between self-reactivity and thymic education mechanisms 
would be useful to discriminate between these potential models for establishing self-
tolerance.   
I addressed this question by analyzing a panel of TCRs with different affinities for 
OVA peptide:MHC molecules for their in vivo response to the RIP-mOVA model 
antigen. While using a single antigen transgenic line has technical advantages as it should 
fix the amount and distribution of the antigen, another important consideration is that it 
models a tissue specific, rather than ubiquitous, antigen.  Whereas T cell autoimmunity to 
ubiquitous antigens is not well described, tissue specific antigens are likely targets in a 
number of human autoimmune diseases such as Hashimoto’s thyroiditis and type 1 
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diabetes. Thus, understanding tolerance to a model tissue specific antigen may be 
clinically relevant.   
These data suggests that tolerance mechanisms to tissue specific antigens 
expressed in the thymus are broad and robust.  I was surprised to observe that Treg cell 
development to this model tissue-specific self-antigen still occurs with TCRs which are ~ 
1000 fold less sensitive to OVA peptide in comparison with the reference TCR DO11, 
which represents a typical agonist interaction with foreign antigen.  Although I did not 
perform a direct measurement of affinity, the steady state tetramer binding studies in 
conjunction with the broad range of functional assessments of TCR reactivity provide a 
clear estimate of relative affinity for this panel of TCRs compared with the DO11 TCR.  
It is interesting to contrast these results from analysis of negative selection of a CD8
+
 
TCR, in which a narrow affinity range was observed [13].  Whether this is explained by 
differences in the assays used, or whether this reflects a fundamental difference between 
T cells at different stages of development or MHC restriction, will need to be clarified by 
future studies.  None-the-less, in contrast with CD8 negative selection, the range of 
affinity that the immune system considers of sufficient self-reactivity to warrant thymic 
Treg cell generation is extremely broad.      
I also observed that the level of self-reactivity is directly correlated with the 
efficiency of thymic Treg cell generation.  In fact, thymic Treg cell development 
appeared indistinguishable from any other in vitro or in vivo TCR-dependent process.  
These data therefore support the notion that one of the primary purposes of TCR 
activation this particular stage in development is Treg cell generation, which appears to 
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wane during T cell maturation [59, 81].  Thus, the TCR's autoimmune potential dictates 
its ability to generate thymic Treg cells. 
The relationship between TCR affinity and the efficiency of thymic Treg cell 
generation is also manifest in the apparent “niche” size, e.g. the number of Treg cells 
generated, even though the physical antigen niche is likely stable due to the use of single 
transgenic line to express OVA as “self-antigen.”  This may arise via two possible 
mechanisms.  One is that the stronger the TCR signal is interpreted in an analog manner 
increasing the likelihood that Foxp3 will be induced.  Alternatively, the TCR signal is 
interpreted in a digital manner such that only APCs that present sufficient antigen can 
induce Foxp3 by exceeding a threshold of TCR signaling.  Increased affinity would 
therefore expand the number of APCs that could generate sufficient TCR signals.  
Although direct evidences to test these hypotheses are required, the former model would 
predict that TCR affinity would affect the slope of Treg cell generation as clonal 
frequency decreases.  Rather, I observed that TCR affinity shifted the entire curve with 
almost same slope, such that higher TCR affinities resulted in enhanced Treg cell 
generation at higher clonal frequencies, suggestive of a larger developmental “niche.”  
Moreover, a recent study of TCR activation using a Nur77-GFP reporter is consistent 
with a signaling threshold for Treg cell development [43].  Thus, I favor the interpretation 
that higher TCR affinity increases the number of APCs that can deliver a threshold level 
of TCR stimulation.   
Although the affinity of the TCR for self-antigen and the Treg cell niche size is 
directly correlated, this may only be true at higher clonal frequencies for TCRs with 
agonist level affinity for self-antigen.  It appears that negative selection likely perturbs 
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this linear relationship at lower clonal frequencies, as T cells encountering self-antigen 
are often deleted instead of becoming Treg cells.  While it has been difficult to quantify 
the role of intraclonal competition for negative selection, this may be expected based on 
studies of Treg cell development [39, 40] and positive selection [50].  
The threshold of observable negative selection appears to be substantially higher 
than that of Treg cell differentiation.  However, it must be noted that the sensitivity of 
detecting Foxp3 induction as determined by the induction of Foxp3
gfp
 is excellent, 
whereas measuring the loss of cells is comparatively insensitive.  It may be possible that 
negative selection occurs at lower affinity, but cannot be measured.  However, trace 
levels of negative selection is unlikely to have any impact on immune tolerance, as 
essentially the same number of self-reactive T cells escapes the thymus, whereas a small 
amount of Treg cell development may have a substantial impact due to the importance of 
Treg cells in dominant tolerance.  
Thymic Treg cell generation may be considered a window into how the immune 
system perceives the need to combat self-reactivity during development prior to the 
export of cells into the periphery.  In comparison with thymic responses, I found that the 
TCR affinities requwered for peripheral T cell responses were much higher than that 
requwered for thymic Treg cell selection, and rather more similar to that requwered for 
negative selection.  While these data wwell need to be validated for other model self-
antigens, and if possible, true self-antigens if they can be genetically changed without 
affecting function, this suggests that the range of self-reactivity requwered for Treg cell 
selection is substantially below that requwered for peripheral T cell responses.   
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In summary, these data using a model tissue specific antigen suggest that the 
immune system utilizes straighforward rules for determining the thymic Treg cell 
population.  Self-reactivity within a broad range, but above that for positive selection, 
selects for Treg cells in a graded manner depending on the extent of self-reactivity.  
Cognate, or agonist levels of self-reactivity also result in negative selection.  In this 
manner, the immune system selects for a Treg cell population which is highly tuned 
towards high affinity self-antigen recognition while including some low affinity TCRs.  
Together with deletion of high affinity TCRs, these rules imprint the self-antigen 
repertoire on the Treg cell population.  Interestingly, I found that incidental self-reactivity 
can also clearly generate Treg cells to foreign antigens, which is consistent with studies 
showing that a small fraction of cells binding to tetramers of foreign antigens are Treg 
cells [82].  Thus, self:non-self discrimination likely revolves around the quantitative bias 
of the TCRs amongst the Treg and naïve T cell population. 
These data clarify how self-reactivity in the CD4
+
 T cell subset is constrained by 
the immune system.  Based on these data, I would predict that the bulk of the TCRs that 
cause autoimmune disease would be of higher affinity than R4, which is ~ 15 fold less 
sensitive than DO11. These TCRs are low enough affinity to avoid marked negative 
selection and incompletely drive thymic Treg cell selection, permiting the escape of self-
reactive naïve T cells [16]. Under normal circumstances, it is difficult to imagine that 
these escaped self-reactive T cells could overcome the suppression by the thymic Treg 
cell population concomitantly generated in response to a broad range of self-reactivity. It 
seems that pro-inflammatory conditions that obviate or block Treg cell suppression 
would be requwered to release these potential autoimmune effector cells.  Such an 
60 
 
inciting event is often not obvious in spontaneous human autoimmunity.  One interesting 
future question is whether the B6 genotype studied here has an unusually low threshold 
for thymic Treg cell generation, as it is known to be resistant to spontaneous 
autoimmunity. Perhaps other autoimmune prone backgrounds wwell requwere a higher 
threshold of self-reactivity for thymic Treg cell generation.  Alternatively, these robust 
thymic mechanisms may hint at the possibility that spontaneous autoimmunity may not 
result from a failure of central tolerance, but rather occurs to antigens that are poorly 
expressed in the thymus.  For example, no indication was found in mixed bone marrow 
chimeras that the self-reactive TCR 2D2 induces thymic Treg cell generation even at low 
clonal frequencies (not shown), suggesting that the MOG-epitope is either not presented 
in the thymus or the affinity of the 2D2 TCR for MHC-MOG peptide complex is too low 
relative to the amount of thymic MOG-peptide.  Future studies wwell be required to test 
the hypothesis that sponatneous autoimmunity is primarily a failure of peripheral 
tolerance.   
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Chapter 3 
Rare development of thymic Treg cells at CD4
+
CD8
+
 subset 
 
Introduction 
Natural CD4
+
Foxp3
+
 Treg cells are essential for preventing autoimmunity [83].  
Although peripheral generation of Treg cells has been demonstrated [84], recent studies 
suggest that the majority of peripheral Treg cells arise via thymic Treg cell development 
[33-35, 85].  One popular model for thymic Treg cell development is that Treg cells are 
selected based on TCR avidity for self-antigens at a level between positive and negative 
selection [61], which is supported by studies demonstrating that the thymic Treg and non-
Treg TCR repertoires differ [33-35, 52].  Thus, TCR specificity for self-antigens appears 
to play an important role in Treg cell development.   
As the APCs encountered by thymocytes can differ substantially between certain 
steps in thymic development [86, 87], the stage at which self-reactive thymocytes become 
Treg cells may play an important role in determining the TCR repertoire of the natural 
Treg cell population.  DP cells are typically found in the thymic cortex, in which the 
predominant APCs are cortical thymic epithelial cells (cTECs).  By contrast, mature 
CD4SP cells are typically found in the medulla, where medullary thymic epithelial cells 
(mTECs) and bone marrow derived dendritic cells are commonly found.  These different 
APC subsets appear to utilize different lysosomal proteases for antigen processing, as 
cTEC use cathepsin L, whereas thymic dendritic cells and mTEC dominantly use 
cathepsin S [53].  In addition, expression of the transcription factor Aire expands the 
array of tissue-specific antigens presented by mTECs [88], which may be important for 
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Treg cell selection [46].  These data therefore suggest that the antigenic environment 
likely differs for DP versus CD4SP cells. 
Several studies have demonstrated that Foxp3
+
 Treg cell lineage commitment can 
occur at the DP stage of thymic development.  First, Foxp3
+
 DP cells can be found in 
TCR transgenic mice in which the T cells encounter their cognate antigen in the thymus 
[61, 89]. Second, cTEC-restricted expression of MHC class II is sufficient to induce the 
generation of Foxp3
+
 T cells [55, 56].  Finally, analysis of Foxp3-knockin reporter mice 
revealed that Foxp3
+
 cells can be found in the DP subset [19, 57, 65, 90], which has been 
reported to represent precursors to Foxp3
+
 CD4SP cells [57].  The fraction of total 
Foxp3
+
 thymocytes in the DP stage ranges between ~5 – 30% depending on the gating 
scheme and report [57, 65].  Thus, a substantial fraction of Treg cells acquire Foxp3 
expression at the DP stage of thymic development.   
I reasoned that the TCR repertoire of Foxp3
+
 DP cells would be different from 
that observed for Foxp3
+
 CD4SP cells [33-35] due to differences in antigen presentation 
at these stages of thymic development.  However, highly purified populations of Foxp3
+
 
DP cells could not be obtained by flow cytometric sorting.  Here, I show that this 
difficulty arises primarily from Foxp3
+
CD4SP:Foxp3
–
DP doublets being recognized as 
Foxp3
+
 DP cells.  Thus, our data demonstrate that the proportion of Foxp3
+
 Treg cells in 
the DP stage is much lower than previously reported, and argue for a minor role for 
Foxp3-induction at the DP stage in the generation of the thymic Treg cell subset.  
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Materials and Methods 
1. Mice  
Foxp3
gfp
 reporter mice was kindly provided by Dr. Alexander Rudensky [65]; 
MHC class II deficient mice [28] were purchased from the Jackson Laboratory (Bar 
Harbor, ME); and B6.SJL CD45.1 congenic mice were purchased from the National 
Cancer Institute (Frederick, MD).  Mice were analyzed at 6-9 weeks of age, housed in 
specific pathogen-free facility at Washington University, and used under protocols 
approved by the Animals Studies Committee.  
 
2. Flow cytometry and FACS cell sorting.  
Monoclonal antibodies were purchased from eBioscience (San Diego, CA) and 
Biolegend (San Diego, CA).  Flow cytometric analysis and sorting were performed using 
a FACSAria (Becton Dickinson, San Jose, CA) and FlowJo software (Tree Star, Ashland, 
OR).  For routine flow cytometry, thymocytes were stained at 40x10
6
 /ml in Ca
++
/Mg
++
 
free DPBS supplemented with 2.5% FCS and 0.02% sodium azide for 20 minutes on ice.  
Free antibody was removed by washing after centrifugation. To reduce cell:cell 
interaction in certain experiments, I stained in the presence of 1mM EDTA at 4°C with 
constant rotation; and instead of washing after centrifugation, the cells were simply 
diluted 50 fold in PBS immediately prior to flow cytometry. To assess DNA content, 
thymocytes were stained with antibodies under the condition for routine flow cytometry, 
and fixed by 0.1% paraformaldehyde in DPBS for at least 2 hours. Fixed thymocytes 
were permeablized using 70% ethanol for propidium iodide staining.     
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3. Neonatal bone marrow chimera.  
Bone marrow cells from Foxp3
gfp
 mice were T-cell depleted using AutoMACS 
magnetic bead removal of CD4 and CD8 labeled cells (Miltenyi Biotech, Auburn, CA). 
Ten million bone marrow cells were intraperitoneally injected into 2-day old mice.  
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Results 
Flow cytometric analysis of Foxp3
+
 DP thymocytes 
Previous studies have demonstrated Foxp3
+
 DP cells in both TCR transgenic and 
polyclonal settings [55, 56, 65, 90], with up to ~30% of Foxp3
+
 thymocytes reported to 
be present in the DP subset [57].  I reasoned that Foxp3
+
 DP and CD4SP cells may 
represent Treg cells selected on different arrays of peptide:MHC class II complexes 
presented on cortical versus medullary APCs, which could be revealed by a comparison 
of the TCR repertoires between DP and CD4SP Foxp3
+
 cells.  However, initial attempts 
to purify Foxp3
+
 DP cells by our usual flow cytometric sorting parameters were 
hampered by low purity in the 40-60% range (Figure 3.1).  Even double FACS 
purification did not result in a high purity sort (data not shown).  This did not appear to 
be a mechanical limitation of the sorter, as Foxp3
+
 CD8SP cells could be sorted with 
reasonable purity, even though they are at comparable frequency to Foxp3
+
 DP cells.   
Post-sort analysis of Foxp3
+ 
DP cells showed that a large portion of the 
contaminants were Foxp3
–
 DP cells (Figure 3.1).  This was expected since Foxp3
–
 DP 
cells are by far the most frequent cell-type in the thymus. Surprisingly, many of the 
contaminants were Foxp3
+
 CD4SP cells.  Since these cells represent only ~0.3% of total 
thymocytes, this suggested that contamination was occurring in a non-random fashion.  
Because these contaminants Were present at a 1:1 ratio (Figure 3.1, bottom), this hinted 
at the possibility that many of the Foxp3
+
 DP cells recognized by flow cytometry may 
represent doublets of Foxp3
–
 DP and Foxp3
+
 CD4SP cells.   
To test this hypothesis, I performed additional flow cytometric analysis of Foxp3
+
 
DP cells.  An appreciable frequency of Foxp3
+
 in the DP subset was only observed only 
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when generous forward scatter-area (FSC-A) and side scatter-area (SSC-A) gating 
parameters were used (Figure 3.2A, large gate).  Area parameters are derived from the 
integration of height and width parameters (e.g. FSC-H and FSC-W) as the cell passes 
through the detector.  However, I found that most Foxp3
+
 DP cells exhibited an 
exaggerated FSC-W compared to FSC-H.  The same was true for SSC (data not shown).  
This traditionally implies that two cells serially passed the detector so close together that 
they could not be discriminated by the cytometer as individual cells.  Rather, this event 
appears as a single large cell with increased FSC-A/SSC-A due to integration.  Consistent 
with this interpretation, a smaller FSC/SSC gating scheme (small gate) decreased the 
frequency Foxp3
+
 cells in the DP subset by approximately 20 fold, and eliminated most 
of the doublets by FSC-H/FSC-W criteria (Figure 3.2A).  Another interesting observation 
is that the MFI of CD4 is approximately two-fold greater on Foxp3
+
 DP cells compared 
with Foxp3
–
 DP cells (Figure 3.3A).  Taken together, these additional flow cytometric 
analyses support the notion that most Foxp3
+
 DP events are comprised of doublets.   
To assess whether doublet formation occurred in vitro during cell-surface labeling 
with fluorescent antibodies, I attempted to decrease cell-cell interactions by avoiding 
centrifugation and staining in the presence of 1mM EDTA.  I found that the frequency of 
singlets in the large gate improved considerably, with a corresponding decrease in the 
frequency of DP cells in the Foxp3
+
 subset (Figure 3.3B, Figure 3.5B). Thus, these data 
suggest that the majority of doublets observed during routine cell staining and processing 
for flow cytometry occur ex vivo.     
To confirm the hypothesis that Foxp3
+
 DP events identified by routine flow 
cytometry are comprised of Foxp3
–
 DP cells adhered with Foxp3
+
 CD4SP cells, I mixed 
67 
 
CD45.1 Foxp3
gfp
 thymocytes with CD45.2 Foxp3
WT
 thymocytes prior to staining and 
flow cytometry.  While Foxp3
+ 
CD4SP and Foxp3
+ 
CD8SP cells appropriately expressed 
only CD45.1, CD45.2 staining was readily apparent on many Foxp3
+ 
DP events (Figure 
3.4A).  Assuming that doublet formation was similar between CD45.1 and CD45.2 cells, 
this would imply that over 80% of Foxp3
+
 DP events identified under these conditions 
were comprised of doublets generated ex vivo.  The efficiency of doublet formation in 
vitro was also dependent on cell concentration during staining (Figure 3.5).  In addition, 
Foxp3
+
 flow cytometric events with high DNA content were preferentially found in the 
DP subset (Figure 3.6).  Thus, these data directly demonstrate that doublets are formed ex 
vivo and are preferentially found in the Foxp3
+
 DP gate.  
Using this mixing assay to assess doublet formation, I then tested the efficiency of 
height by width parameters for “doublet discrimination” gating. I observed that the 
frequency of doublets markedly increased as the FSC-H size of the gate increases even if 
the FSC-W gating remains unchanged (Figure 3.4B, Figure 3.7).  Furthermore, the 
increase in the frequency of Foxp3
+
 cells in the DP gate (Figure 3.4C) parallels the 
frequency of doublets associated with larger FSC-H gates (Figure 3.4B).  Conversely, the 
frequency of Foxp3
+
 cells in the CD4SP subset decreases (Figure 3.4C).  Thus, while 
“doublet discrimination” gating is useful to eliminate doublets which pass through the 
detector in series, it can be defeated by a generous FSC-H (and SSC-H) gate, thereby 
including doublets which pass through in parallel. Taken together, these data demonstrate 
that the frequency of DP cells in the Foxp3
+
 subset is substantially less than previously 
reported [57], representing approximately 1% of Foxp3
+
 thymocytes (Table 3.1). 
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Characterization of Foxp3
+ 
DP thymocytes 
As it is unclear whether previous studies excluded doublets from the analysis of 
Foxp3
+
 DP events, I performed a flow cytometric characterization of Foxp3
+
 DP cells 
using a small gate.  One observation was that the levels of CD4 and CD8 are lower than 
those found on typical Foxp3
–
 DP cells (Figure 3.2, small gate), suggesting that Foxp3
+
 
DP cells Were transitioning out of the DP stage after undergoing positive selection.  This 
is consistent with the observation that Foxp3
+
 DP cells are TCR
hi
 and express lower 
levels of HSA than Foxp3
–
 DP cells (Figure 3.7). However, the HSA levels on Foxp3
+
 
DP cells were higher than those on Foxp3
+
 CD4SP cells.  In addition, Foxp3
+
 DP cells 
show higher level of CD69 expression than Foxp3
–
 DP, indicating that Foxp3
+
 DP cells 
may have recently received a positively selecting TCR signal.  In other respects, DP and 
CD4SP cells were similar, expressing Treg surface markers such as CD25, GITR, OX-40 
and CD103 (Figure 3.8). Thus, these data suggest that Foxp3
+
 DP cells have undergone 
positive selection and express traditional Treg cell markers. 
Since most Foxp3
+
 thymocytes are presumably MHC class II restricted as most 
reside in the CD4SP subset, I asked whether Foxp3
+
 DP cells require MHC class II for 
their development.  Consistent with a previous report [65], I observed a marked decrease 
in Foxp3
+
 CD4SP cells and a increase in Foxp3
+
 DP and CD8SP cells in Foxp3
gfp
 MHC 
class II deficient mice (Figure 3.9A).  This was also reflected in an overall decrease in 
frequency of Foxp3
+
 thymocytes (Figure 3.9B).  Curiously, many Foxp3
+
 DP cells in 
MHC class II-deficient mice in the large gate by FSC-A/SSC-A parameters show 
enhanced levels of CD8 compared to their counterpart in wild-type mice.  Since these 
cells are not present when the small gate is used, they may represent doublets of Foxp3
+
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DP or CD8SP cells with Foxp3
–
 DP cells in MHC class II-deficient mice.  Nonetheless, 
the presence of Foxp3
+
 CD4
lo
CD8
lo
 DP cells in MHC class II-deficient mice suggest that 
Treg cell selection can occur on MHC class I.   
 
Developmental kinetics of Foxp3
+
 thymocytes 
A previous study of neonatal thymic development showed that Foxp3
+
 DP and 
CD4SP cells appeared coincidently [19].  Since this study examined development in a 
neonatal and potentially lymphopenic thymic setting, it was possible that the thymic 
medulla was not fully mature [91-93].  I therefore analyzed T cell development in 
lymphoreplete thymuses using neonatal bone marrow chimeras.  It took approximately 
2.5 weeks post transfer of congenically marked bone marrow cells to see appreciable 
numbers of developing donor thymocytes (Figure 3.10A). I did not observe a period in 
which DP cells contributed a substantial fraction to the total thymic Foxp3
+
 population 
(Figure 3.10B).  Curiously, the frequency of Foxp3
+
 cells with the CD4SP subset 
increased over a period of approximately 1.5 weeks until it reached steady state, 
consistent with a delay in Foxp3
+
 cell development at the CD4SP stage (Figure 3.10C) 
observed in neonatal mice [19].  These data therefore illustrate that the temporal delay in 
the generation of Foxp3
+
 as compared with Foxp3
–
 CD4SP cells does not result from 
conditions unique to the neonatal thymus. 
I also examined the kinetics of Foxp3
+
 Treg cell development in the CD4SP stage.  
Although this time course analysis cannot prove precursor:product relationships, it 
appears that Foxp3
+
 cells arise from the HSA
hi
 CD4SP subset before downregulating 
HSA (Figure 3.10D).  Furthermore, Foxp3
–
CD25
+
 CD4SP cells, which have been 
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suggested to be enriched in thymic Treg cell precursors [52], are found initially at much 
higher frequency than Foxp3
+
 cells, but decrease over time as the frequency of Foxp3
+
 
correspondingly increases (Figure 3.10E).  Although correlative, these data imply that 
Treg cell development occurs at the HSA
hi
 CD4SP stage through a Foxp3
–
 CD25
+
 
intermediate.  
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Figure Legends  
Table 3.1.  Summary of CD4/8 distribution of Foxp3
+
 thymocytes   
Data shown are the mean frequency of Foxp3
+
 thymocytes which fall into the DP, 
CD4SP, and CD8SP gates as per Figure 3.2.  EDTA indicates whether 1mM EDTA and 
avoidance of centrifugation was used to diminish cell:cell interactions.  Large and small 
gates represent those shown in Figure 3.2.   
 
Figure 3.1.  Contaminants in sorted Foxp3
+ 
DP thymocytes   
Foxp3
+
 DP thymocytes were sorted from Foxp3
gfp
 mice and analyzed by flow 
cytometry.  Representative plots of two independent experiments are shown. Mean 
percentage (± S.D, n=2) of contaminants in sorted cells is derived from the post-sort 
gating scheme (%CD4SP x %Foxp3
+
 and %DP x %Foxp3
–
). 
 
Figure 3.2.  Most Foxp3
+ 
DP events by flow cytometry appear to be doublets.   
(A) Flow cytometric analysis of Foxp3
+ 
thymocytes.  Thymocytes from Foxp3
gfp
 
mice were stained using our normal protocol and analyzed by flow cytometry.  The large 
(dotted line) and small (black line) gates use the area parameter, which is integrated 
based on the height and width of the signal from an individual event.  FSC-H/FSC-W 
plots are shown on the right for the indicated Foxp3
+
 populations. Using these parameters, 
a doublet often appears to have a larger width than height, unless the doublet crosses the 
beam in tandem.  Numbers in the FACS plots represents the frequency of the cells in the 
indicated gate.  (B) Reduction in Foxp3
+
 DP events using EDTA and avoidance of 
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centrifugation.  Thymocytes from Foxp3
gfp
 mouse were prepared as described in the 
Methods, and analyzed as above.   
 
Figure 3.3.  Most Foxp3
+
 DP events are composed of doublets. 
  (A)  Foxp3
+
 DP events are two-fold brighter for CD4 than Foxp3
–
 DP events. 
Thymocytes from Foxp3
gfp
 mouse were prepared as described in the Methods, and 
analyzed as per Figure 3.2.  Mean fluorescence intensity (MFI) of CD4 is shown for 
events in the large gate above from 3 independent experiments (± S.D.). (B) Reduction in 
Foxp3
+
 DP events using EDTA and avoidance of centrifugation. Representative flow 
cytometric plots analogous to those in Figure 3.2 are shown.  (C) Summary of singlet 
frequencies in Foxp3
+
 DP, CD4SP and CD8SP subsets using the large FSC-A/SSC-A 
gate above.  Each dot represents data from an independent experiment.  
 
Figure 3.4.  Doublets in the Foxp3
+
 DP thymocyte subset  
(A) Foxp3
+
 DP doublets are formed during staining. CD45.2 Foxp3
gfp
 thymocytes 
were mixed with CD45.1 Foxp3
WT 
thymocytes at 1:1 ratio, stained using the normal 
protocol, and analyzed by flow cytometry using a large FSC-A/SSC-A gate (see Figure 
3.2). Data shown are gated on Foxp3
gfp+
 cells and as indicated above the plots, and a 
representative of two independent experiments.  The numbers represent the frequency of 
the cells in the quadrant. (B)  “Doublet discrimination” gating is imperfect for eliminating 
doublets.  Thymocytes in the large FSC-A/SSC-A gate as in (A) were further analyzed 
using gates with small FSC-W and different FSC-H for the frequency of 
CD45.1
+
CD45.2
+
 doublets. Representative plots and quantification of doublets are shown 
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according to FSC-H value.  (C) Frequency of Foxp3
+
 DP cells is proportional to doublet 
formation.  The mean frequencies of DP and CD4SP in Foxp3
+
 thymocytes from each 
FSC-H gate are plotted.   
 
Figure 3.5.  Increased cell concentration during staining enhances the frequency of 
Foxp3
gfp+
 DP events.   
Thymocytes were stained as per Figure 3.4 at the indicated cell concentration and 
analyzed by flow cytometry.  The mean percentages of Foxp3
gfp+
 DP cells which are 
CD45.1
+
, and the frequency of Foxp3
gfp+
 cells which fall in the DP gate, are shown from 
4 independent experiments (± S.D.).  
 
Figure 3.6.  Frequency of Foxp3
+
 DP cells increases with DNA content. 
  Thymocytes were fixed and stained for DNA content as described in the 
Material and Methods section.  DNA content was assessed by flow cytometry of PI 
staining using a large FSC-A/SSC-A and Foxp3
+
 gate.  Data shown are representative of 
2 dependent experiments.  
 
Figure 3.7.  Doublet-discrimination gating decreases the frequency of Foxp3
gfp+
 DP 
events.   
Thymocytes were stained as per Figure 3.4 and analyzed by flow cytometry.  The 
plot on the left was gated using a large FSC-A/SSC-A gate.  On the right, the mean 
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percentages of CD45.1
+
CD45.2
+
 doublets and DP subset in Foxp3
gfp+
 cells in the 
indicated FSC-H/FSC-W gates are shown from 3 independent experiments (± S.D.).  
 
Figure 3.8. Foxp3
+
 DP and CD4SP cells express similar cell surface markers. 
 Thymocytes from Foxp3
gfp
 mice were analyzed for cell surface expression of 
indicated markers on Foxp3
–
 and Foxp3
+
 DP cells; and Foxp3
–
 and Foxp3
+
 CD4SP cells 
as indicated using small FSC-A/SSC-A and doublet discrimination (width/height) gates 
as per Figure 3.2.  Data are representative of 4 mice analyzed.  
 
Figure 3.9.  Foxp3
+
 DP cells can be generated by MHC class I.  
(A) Development of Foxp3
+
 cells in MHC class II-deficient mice.  Foxp3
+
 
thymocytes from wild-type and MHC class II-deficient mice were analyzed using FSC-
A/SSC-A large (dotted line) and small gates (black line). Plots shown are representative 
of three independent experiments.  (B) Reduction of Foxp3
+
 thymocytes generation in the 
absence of MHC class II. The mean percentages of Foxp3
+
 in thymocytes from wild-type 
and MHC class II-deficient mice are shown.  
 
Figure 3.10.  Kinetics of thymic regulatory T cell development    
(A)  Delay in generation of Foxp3
+
 cells in lymphoreplete thymuses.  CD45.2 
Foxp3
gfp
 T cell-depleted bone marrow cells were intraperitoneally injected into 2-day old 
CD45.1 neonates, and donor-derived thymocytes were analyzed by flow cytometry at the 
indicated age.  Data shown are gated on DP or CD4SP cells, and are representative of 
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three independent experiments with at least two mice per time point.  (B) Foxp3
+
 CD4SP 
and DP Treg cells are coincidentally observed.  Mean percentage of cells in the various 
CD4/CD8 subsets amongst the Foxp3
+
 thymocyte population are plotted.  At 2.5 weeks, 
too few Foxp3
+
 events were recorded to allow meaningful comparisons (N/A).  (C)  
Summary of time course of Foxp3
+
 cell generation. The frequency of Foxp3
+
 cells within 
the DP or CD4SP subset is plotted with respect to time after bone marrow transfer.  Data 
shown are mean ±S.D. (n = 3).  (D)  Appearance of HSA
hi
 Foxp3
int
 cells during the initial 
wave of Treg cell development after bone marrow transfer.  Data shown are 
representative flow cytometric plots gated on CD45.1
–
CD45.2
+
 CD4SP cells.  (E)  
Foxp3
–
CD25
+
 and Foxp3
+
 CD4SP cell frequencies are inversely correlated.  Data shown 
are the mean ± S.D., n=3.  
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Large gate Small gate 
EDTA: – + – + 
CD8SP 3.1 ± 0.5 3.2 ± 0.6 4.0 ± 0.1 3.4 ± 0.8 
CD4SP 68.8 ± 10 86.8 ± 0.9 87.8 ± 1.5 91.4 ± 1.2 
DP 21.5 ± 11 4.1 ± 0.2 1.27 ± 0.4 1.4 ± 0.2 
 
 
 
 
 
 
Table 3.1.  Summary of CD4/8 distribution of Foxp3
+
 thymocytes   
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Figure 3.1.  Contaminants in sorted Foxp3
+ 
DP thymocytes    
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Figure 3.2.  Most Foxp3
+ 
DP events by flow cytometry appear to be doublets.    
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Figure 3.3.  Most Foxp3
+
 DP events are comprised of doublets.   
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Figure 3.4.  Doublets in the Foxp3
+
 DP thymocyte subset  
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Figure 3.5.  Increased cell concentration during staining enhances the frequency of 
Foxp3
gfp+
 DP events.    
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Figure 3.6.  Frequency of Foxp3
+
 DP cells increases with DNA content.    
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Figure 3.7.  Doublet-discrimination gating decreases the frequency of Foxp3
gfp+
 DP 
events.    
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Figure 3.8. Foxp3
+
 DP and CD4SP cells express similar cell surface markers.  
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Figure 3.9.  Foxp3
+
 DP cells can be generated by MHC class I.   
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Figure 3.10.  Kinetics of thymic regulatory T cell development   
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Discussion 
These data highlight one circumstance in which identifying rare cell populations 
by flow cytometry is problematic due to the congruence of several factors.  First, the 
gating criteria are based only on positive staining, facilitating the inclusion of doublets.  
By contrast, identifying rare Foxp3
+
 CD8SP cells requires a CD4
–
 gate, excluding 
doublets to everything but another CD8SP cell, which is statistically much less likely 
assuming random interactions.  Second, Foxp3
–
 DP cells represents the vast majority of 
thymocytes, making it likely that random doublet formation would include this subset, 
regardless of whether there are additional attractive forces between Foxp3
+
 CD4SP and 
Foxp3
–
 DP cells.  Third, the actual Foxp3
+
 DP cell population appears to be rare, 
allowing infrequent doublets of Foxp3
+
CD4SP with Foxp3
–
DP to be relatively more 
prominent.  The low frequency of Foxp3
+
 DP cells may further encourage staining under 
more concentrated cell conditions, facilitating doublet formation (Figure 3.5). Moreover, 
the rarity of the cells may prompt more relaxed gating to include as many events as 
possible, diminishing the effectiveness of strategies designed to improve “doublet 
discrimination” (Figure 3.4 B,C).  I believe that relaxed gating resulted in our initial 
inability to sort these rare Foxp3
+
 DP cells with high purity (Figure 3.7).  The use of 
stringent gating criteria is therefore required for more specific identification of Foxp3
+
 
DP cells.   
These data demonstrate that the induction of Foxp3 in the DP stage is a relatively 
rare occurrence.  Although the use of a small gate may result in the exclusion of larger 
Foxp3
+
 cells which are not doublets, I estimated the frequency of Foxp3
+
 cells that are 
DP cells by flow cytometry to be approximately 1%, which is considerably lower than a 
recent estimate [57].  While I cannot exclude that TCR interactions with self-antigens at 
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the DP stage condition thymocytes to undergo Treg cell development in a multi-step 
process [52], these data suggest that the vast majority of Foxp3 acquisition occurs at the 
immature HSA
hi
 stage of CD4SP development (Figure 3.10), and favor a model in which 
Treg cell development in the DP and CD4SP stage occur in parallel, rather than in serial 
[94].   
In addition to the enumeration of Foxp3
+
 DP cells, these results illustrate the 
difficulty of studying with this rare Foxp3
+
 population.  While a difference of 1% versus 
3% Foxp3
+
 cells in the DP gate may be of little importance with regard to the role of Treg 
cell development in the DP stage, analysis of a cell population in which the majority was 
comprised of doublets would be problematic.  For example, TCR sequences from Foxp3
+
 
DP event would have been difficult to interpret due to contamination with CD4SP Treg 
cells.  Thus, great care should be taken with functional, developmental, or phenotypic 
evaluation of Foxp3
+
 DP cells to avoid the potential for bias by inclusion of Foxp3
+
 
CD4SP cells due to doublets.   
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Chapter 4 
Concluding Remarks and Future Directions 
 
As Foxp3
+
 CD4
+
 Treg cells plays an important role in the maintenance of 
tolerance to self, studying the development of Treg cells is essential to understand 
tolerance mechanism required to prevent autoimmunity. I have studied differentiation of 
thymic Treg cells using TCR repertoire analysis by addressing two questions. How does 
self-reactivity of TCR drive Treg cell development? (Chapter 2) When does 
differentiation of Treg cells occur in the thymus? (Chapter 3) In my dissertation study, I 
showed that differentiation of thymic Treg cells is instructed by TCR reactivity for self-
antigen presented by mTEC, thereby most of Treg cells appear at immature CD4SP stage. 
Moreover, assessment of the effect of TCR affinity in negative selection and peripheral T 
cell response gave an insight of how self-reactivity of TCR operates to establish self 
tolerance and to prevent autoimmunity.  
 
How much self-reactivity is required for thymic Treg cell development? 
Although the notion that self-reactivity plays a critical role in thymic Treg cell 
development has been supported by many reports for a decade, the degree of T cell self-
reactivity considered dangerous by the immune system, thereby requiring thymic 
education to prevent autoimmunity, is unknown. I analyzed a panel of TCRs with a broad 
range of reactivity to ovalbumin (OVA323-339) in the RIP-mOVA self-antigen model for 
their ability to induce mechanisms of thymic tolerance.  In Chapter 3, I quantified TCR 
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specificity and correlated it with thymic T cell selection, such as Treg development and 
negative selection. Thymic Treg cell generation in vivo was directly correlated with 
reactivity to OVA-peptide in a broad ~1,000-fold range, and its developmental “niche 
size” was unexpectedly dependent on TCR affinity.  The threshold for Treg cell 
differentiation was almost 100-fold lower than that required for eliciting thymic negative 
selection and peripheral T cell responses. Thus, these data suggest that Treg cell 
differentiation is a default outcome of self-antigen encounter for CD4
+
 thymocytes, and 
that thymic tolerance mechanisms are tuned to limit the escape of self-reactive effectors 
without Treg cell chaperones into the periphery. 
 
Timing of Treg cell development in the thymus 
The CD4
+
CD8
+
 (DP) stage of thymic development has been thought to be the 
earliest period which generates natural Treg cells important for the prevention of 
autoimmunity.  However, I found that most Foxp3
+
 DP cells identified by routine flow 
cytometry represent doublets comprised of Foxp3
–
 DP and Foxp3
+
 CD4
+
CD8
–
 (CD4SP) 
cells.  This was determined using analysis of flow cytometric height and width 
parameters, post-sort contaminants, and thymocyte mixing studies.  Temporal analysis of 
Treg cell development arising from bone marrow precursors in neonatal bone marrow 
chimeras suggested that Foxp3
+
 DP cells are not a major percentage of Foxp3
+
 
thymocytes, and supported the notion that most Treg cell development occurred at the 
immature HSA
hi
 CD4SP stage.  Thus, these data demonstrate that the frequency of 
Foxp3
+
 cells generated at the DP stage is much smaller than previously recognized, 
suggesting that additional thymocyte maturation may be required to facilitate efficient 
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induction of Foxp3. In addition, this study highlights a potential bias which may happen 
in identifying very rare population among DP cells comprising most of thymocytes. 
 
Questions to be addressed 
Observations from my dissertation study, lead to interesting questions regarding 
the role of TCR affinity in mechanisms of establishing tolerance to self in the thymus and 
periphery. Does thymic Treg cell differentiation utilize continuous signaling mode or 
digital threshold mode? Does interclonal competition inhibit Treg cell development of 
lower affinity TCRs? How does TCR affinity affect effector versus Treg cell generation 
in the periphery?  Does the level of self-reactivity control suppressor function of Treg 
cells? A panel of OVA-reactive TCRs obtained in this dissertation would be useful to 
address these questions. 
 
TCR signaling mode for thymic Treg cell development 
It was demonstrated that Treg cell differentiation is driven by self-reactivity to 
likely non-ubiquitous tissue-specific antigen, and that this is reflected in the size of the 
Treg cell developmental niche in my dissertation study. This leads to an important 
question. How is the level of TCR-antigen interaction translated into Foxp3 expression? 
This may be explained in two different models. One model is that there is a TCR 
stimulation threshold required for Foxp3 induction. Another model is that the level of 
TCR stimulation translated into the degree of Foxp3 expression in continuous manner, by 
which strong TCR stimulation increases the probability of Foxp3 induction. The 
approach to address this question would be using the panel of OVA-reactive TCRs to 
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examine whether TCR signals are interpreted in a digital or analog manner for Foxp3 
expression. To evaluate the strength of TCR signaling in vivo, we obtained a new 
reporter mouse, Nur77-GFP [43] from Dr. Hogquist (U of Minnesota), and are breeding it 
to Rag1
–/–
 in B6.C background to obtain donor DN thymocytes for retroviral bone 
marrow chimera or intrathymic transfer.  
If Treg cell development occurs in digital threshold model, it would be expected 
to be observed that Treg cells will always show a certain level of GFP irrespective of 
TCR affinity, in which lower affinity TCRs results in less number of cells with the same 
GFP level, while the level of effector T cells would vary with TCR affinity. On the other 
hand, if Treg cell differentiation is based on continuous TCR signaling, the level of GFP 
in Treg cells would differ depending on TCR affinity, where intensity of GFP from Treg 
cells decreases with lower TCR affinity. Since c-Rel has been reported to play a primary 
role in Treg cell development by interpreting TCR stimulation into Foxp3 expression [95-
98], it would be worth to examine whether NF-κB pathway is activated in digital manner.   
  
Interclonal competition in thymic Treg cell development 
Although it was shown that the size of Treg cell development niche is dependent 
on TCR affinity to self-antigen, it remains unclear how thymocytes with various affinity 
interact with the limited niche. Thus, it would be interesting to examine whether there is 
interclonal competition among self-reactive thymocytes for the same self-antigen, and 
whether it inhibits Treg cell differentiation of thymocytes with lower self-reactivity. The 
panel of OVA-reactive TCRs would be useful tool to test the hypothesis that interclonal 
competition may favor the differentiation of Treg cells of higher self-reactivity, while 
93 
 
cells with lower self-reactivity develop as effector cells. If interclonal competition is 
observed, it would suggest that TCRs with lower affinity for self-antigen is more likely to 
escape thymic tolerance mechanism as effector cells, potentially autoimmune T cells, 
whereas self-reactive TCRs have higher probabilities of undergoing thymic education to 
preserve tolerance.  
To test whether high affinity TCR would affect Treg cell development of the 
other TCR, a TCR in the panel (e.g. N7) would be transferred with DO11, the highest 
affinity TCR in, into the of congenic hosts. One expected outcome from this experiment 
is that DO11 has no effect on development of the second TCR into Treg cells, suggesting 
that niche size is sufficient for Treg cell differentiation of both TCRs. This may suggest 
that Treg cell development occurs independently in terms of self-reactivity of thymocyte 
population. On the other hand, Treg cell differentiation may be hindered by higher 
affinity TCRs. This may imply that lower affinity TCRs are outcompeted by higher 
affinity, resulting in escape of thymocytes with lower affinity from thymic tolerance 
mechanism, becoming effector T cell subset.   
 
Interclonal competition for peripheral antigenic niche 
The degree of self-reactivity of TCR was demonstrated to play an instructive role 
in thymic Treg cell generation in this study. Self-reactivity is also known to drive 
peripheral autoimmune responses [85, 99]. However, the relationship of self-reactivity 
between thymic and peripheral tolerance is unknown. Moreover, the level of self-
reactivity inducing peripheral Treg cell generation compared to that of autoimmune 
effector cells is unknown. Thus, it would be interesting to see how TCRs with varying 
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affinities compete for the same peripheral antigenic niche, and whether high affinity 
TCRs outcompete low affinity ones in competition peripheral self-antigen, resulting that 
the antigen specific Treg cell pool is mostly filled with Treg cells with high affinity TCRs. 
The panel of OVA-reactive TCRs will be used to study the quantitative role of self-
reactivity in peripheral tolerance as well. Peripheral CD4 T cells expressing individual 
OVA-reactive TCR will be transferred into RIP-mOVA hosts and assessed for Treg 
versus effector T cell development by flow cytometry. One possible outcome is that self-
reactivity of TCR will be correlated with peripheral generation of Treg cell. By contrast, 
TCR affinity may not contribute much to Treg cell generation unlikely its instructive role 
in the thymus. This would suggest that other factors besides TCR affinity control cell fate 
into Treg cells in the periphery. 
 
Role of TCR affinity for Treg cell suppression of autoimmunity  
Given that Treg cells need TCR stimulation to exert their suppressive function, it 
is unknown whether Treg cells recognize same self-antigen as effector T cells to protect 
autoimmunity. Moreover, it has not been studied which level of self-reactivity in the Treg 
cells is required to suppress autoimmune effector T cells. These questions would be 
directly addressed using OVA-reactive TCRs generating Treg cells with varying affinities. 
Initially, naïve T cells will be sorted and transferred into RIP-mOVA Rag1
-/-
 hosts to 
determine the level of TCR affinity required to induce autoimmune diabetes. After 
establishing conditions for diabetes induction in RIP-mOVA Rag1
-/-
 mice, Treg cells 
expressing individual TCR will be co-transferred with naïve T cells to determine the level 
of self-reactivity of Treg cells to prevent or mitigate diabetes. Results from this study 
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could address a question whether Treg cells need to have a higher or equal affinity to 
peripheral self-antigen for efficient suppression of effector T cells. 
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